Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024474	li-alb	mg/l (mg/l)	3033	3252	0.00%
3024474	li-alb	— (—)	465	492	100.00%	Distribution not available
3024474	li-alb	g/l (mg/l)	33	34	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Visual disturbances and blindness

680

1348

5.16

321.62

1.1

268.21

259.05

mg/l

0.18

604

1182

Visual disturbances

654

1270

5.27

316.85

1.1

266.57

256.03

mg/l

0.21

583

1115

Autoimmune diseases related-to ILD

1006

2343

3.83

315.18

1.1

232.45

279.68

mg/l

6.13

867

2072

Postprocedural disorders of nervous system

294

226

14.27

312.76

1.1

1.0

213.46

220.62

mg/l

0.18

255

191

Other degenerative diseases of the nervous system

763

157

38.89

307.65

1.1

231.19

256.06

mg/l

0.65

665

144

Neurological diseases

1181

628

9.63

307.65

1.1

1.0

252.83

247.97

mg/l

0.13

1036

557

Neurological diseases, wide definition

528

148

18.28

307.65

1.1

240.27

223.70

mg/l

0.45

458

133

MS-disease / Multiple Sclerosis

564

197

34.85

307.65

1.1

215.91

226.01

mg/l

0.48

487

170

Symptoms and signs involving the nervous and musculoskeletal systems

1055

1382

7.87

307.65

1.1

258.39

267.28

mg/l

0.39

904

1240

Demyelinating diseases of the central nervous system

672

230

35.58

307.65

1.1

217.46

238.12

mg/l

1.06

589

200

Other demyelinating diseases of the central nervous system

342

47.74

307.65

1.1

212.42

224.44

mg/l

0.35

300

Disorders of optic nerve and visual pathways

332

267

13.50

307.65

1.1

1.0

248.40

239.39

mg/l

0.10

282

235

Polyneuropathies and other disorders of the peripheral nervous system

382

407

9.76

307.65

1.1

332.39

290.06

mg/l

1.49

348

351

Disturbances of skin sensation

640

837

7.99

307.65

1.1

229.44

250.79

mg/l

0.86

567

731

Other symptoms and signs involving the nervous and musculoskeletal systems

798

1038

7.95

307.65

1.1

244.42

251.28

mg/l

0.34

683

929

Abnormal findings on diagnostic imaging of central nervous system

263

102

30.28

307.65

1.1

242.04

237.98

mg/l

0.07

224

Symptoms and signs involving the skin and subcutaneous tissue

815

2024

4.07

287.80

1.1

249.91

268.30

mg/l

0.69

715

1778

Headache

805

1606

4.25

285.60

1.1

241.00

260.01

mg/l

0.66

703

1419

Other and unspecified polyneuropathies, also in other diseases

328

338

10.09

285.02

1.1

310.54

303.71

mg/l

0.15

299

287

Autoimmune diseases excluding thyroid diseases

1151

1806

3.58

280.78

1.1

255.75

272.76

mg/l

0.84

1003

1594

Autoimmune diseases excluding thyroid diseases, strict definition

1131

1762

3.62

280.61

1.1

256.24

274.29

mg/l

0.89

987

1554

Optic neuritis

220

125

20.11

276.36

1.1

1.0

207.38

217.16

mg/l

0.38

185

107

Other neurological diseases

738

1408

4.28

260.41

1.1

271.22

283.73

mg/l

0.30

639

1244

Autoimmune diseases

1070

1815

3.04

198.70

1.1

251.21

272.49

mg/l

1.19

941

1601

General symptoms and signs

1066

1770

3.05

197.36

1.1

262.31

267.54

mg/l

0.14

927

1563

Concussion

342

460

6.49

196.81

1.1

1.0

259.44

242.33

mg/l

0.30

296

411

ILD medications: immunosuppressive drugs

674

1838

3.57

195.27

1.1

244.73

280.70

mg/l

2.52

572

1631

Encephalitis

139

25.18

192.55

1.3

1.0

334.44

229.12

mg/l

3.23

129

Used for control exclusion in common control thyroid runs

1008

1691

3.05

187.84

1.1

253.73

274.17

mg/l

1.03

888

1493

Symptoms and signs involving cognition, perception, emotional state and behaviour

914

2150

3.01

185.49

1.1

259.19

270.47

mg/l

0.48

805

1885

Other encephalitis

132

25.61

183.92

1.3

1.1

341.22

232.72

mg/l

3.12

122

Abnormalities of gait and mobility

192

173

11.54

183.30

1.1

311.68

291.03

mg/l

0.36

158

151

Intracranial trauma

369

481

5.78

178.46

1.1

1.0

258.61

248.64

mg/l

0.16

322

428

Diplopia

224

265

8.78

175.25

1.1

346.50

276.44

mg/l

0.62

200

222

Other symptoms and signs involving cognitive functions and awareness

396

802

4.70

165.68

1.1

283.43

283.04

mg/l

0.01

349

698

Inflammatory diseases of the central nervous system

193

218

9.33

157.08

1.2

1.1

375.56

271.88

mg/l

2.71

174

187

ILD medications

1048

2199

2.64

156.06

1.1

242.50

271.11

mg/l

2.43

913

1939

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

533

1399

3.57

153.90

1.1

262.10

294.59

mg/l

1.85

463

1230

Subjective visual disturbances

309

597

5.30

150.96

1.1

249.36

258.27

mg/l

0.10

284

518

Spirochaetal infections, other/unspecified

171

183

9.83

144.98

1.1

373.43

267.89

mg/l

3.79

162

159

Episodal and paroxysmal disorders

1001

1972

2.62

144.21

1.1

236.62

267.90

mg/l

2.91

883

1735

Use of teriflunomide

39.90

142.04

1.0

1.1

212.35

228.26

mg/l

0.25

Malaise and fatigue

422

893

3.98

138.11

1.1

251.53

276.48

mg/l

1.42

368

791

Migraine

542

1475

3.17

126.41

1.1

214.09

233.50

mg/l

1.33

487

1302

Other disorders of optic [2nd] nerve and visual pathways

143

152

9.94

122.00

1.2

1.0

309.16

237.38

mg/l

0.47

121

132

Other soft tissue disorders, not elsewhere classified

824

2029

2.53

117.39

1.1

252.12

264.30

mg/l

0.42

734

1769

Dizziness and giddiness

587

1661

2.89

116.37

1.1

242.82

269.74

mg/l

2.79

519

1454

Dorsalgia

866

1887

2.50

116.32

1.1

251.45

262.55

mg/l

0.52

766

1645

Medical observation and evaluation for suspected diseases and conditions

585

963

3.14

114.93

1.1

247.20

264.99

mg/l

0.99

544

830

Diseases of the eye and adnexa

783

1490

2.65

114.66

1.1

234.17

260.86

mg/l

2.64

688

1307

Other dorsopathies, not elsewhere classified

874

1902

2.44

110.66

1.1

246.36

263.85

mg/l

1.00

786

1658

Nerve, nerve root and plexus disorders

847

2235

2.40

108.64

1.1

273.99

267.03

mg/l

0.26

736

1969

Papilloedema, unspecified

17.21

106.67

1.2

1.0

352.49

222.46

mg/l

0.54

Cerebral cysts

129

144

9.44

106.06

1.1

1.0

306.50

257.92

mg/l

0.26

112

121

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

313

336

4.71

102.85

1.1

255.44

282.61

mg/l

0.87

271

308

Epilepsy

293

764

3.88

97.42

1.1

295.37

261.52

mg/l

0.64

266

681

Cerebral palsy and other paralytic syndromes

173

295

6.04

97.06

1.2

1.1

341.34

275.96

mg/l

0.64

159

253

Other headache syndromes

389

1227

3.21

96.94

1.1

259.36

247.75

mg/l

0.41

333

1080

Pain in joint

478

1056

3.02

96.62

1.1

241.47

277.38

mg/l

2.26

425

915

Care involving use of rehabilitation procedures

519

1864

2.67

91.72

1.1

255.15

268.80

mg/l

0.59

439

1656

Dorsopathies

849

1920

2.27

91.19

1.1

247.27

263.25

mg/l

0.86

753

1674

Abnormal involuntary movements

154

250

6.31

90.69

1.1

1.0

260.50

268.69

mg/l

0.16

137

218

L04AA Selective immunosuppressants

257

651

4.03

89.73

1.1

243.00

259.91

mg/l

0.50

210

572

Low back pain

585

1787

2.54

89.45

1.1

252.99

258.74

mg/l

0.22

515

1555

Other special examinations and investigations of persons without complaint or reported diagnosis

535

963

2.83

88.70

1.1

244.13

264.99

mg/l

1.30

466

830

Systemic atrophies primarily affecting the central nervous system

12.58

88.15

1.1

280.17

278.30

mg/l

0.02

Second line medication for Crohn's disease

497

1889

2.66

88.06

1.1

240.98

260.68

mg/l

1.48

426

1671

Condition for Implicit Sepsis (Organ dysfunction codes)

631

1899

2.43

86.78

1.1

265.86

272.31

mg/l

0.18

554

1672

Pain in limb

632

1908

2.41

85.44

1.1

250.84

261.89

mg/l

0.47

553

1665

L04AX Other immunosuppressants

481

1831

2.65

84.99

1.1

240.00

260.77

mg/l

1.56

411

1625

General examination and investigation of persons without complaint and reported diagnosis

500

963

2.78

81.91

1.1

269.70

264.99

mg/l

0.09

453

830

Cerebrovascular diseases (FINNGEN)

315

655

3.48

81.47

1.1

291.49

267.46

mg/l

0.66

263

581

ILD medications: prednisolone, methylprednisolone, prednisone

817

2142

2.17

81.15

1.1

254.60

273.44

mg/l

1.11

719

1889

Anxiety disorders, excluding more controls

667

1919

2.32

80.99

1.1

236.87

275.00

mg/l

3.45

575

1691

Migraine with aura

266

756

3.57

78.52

1.1

207.80

228.79

mg/l

1.32

238

672

Disorders of ocular muscles, binocular movement, accommodation and refraction

446

1699

2.63

77.39

1.1

255.67

243.91

mg/l

0.19

375

1511

Pain, not elsewhere classified

240

647

3.76

76.57

1.1

299.39

258.73

mg/l

0.53

205

575

Small fibre neuropathy

15.13

76.56

1.1

315.03

243.56

mg/l

1.57

Mood disorders, excluding more controls

716

1993

2.20

75.18

1.1

246.44

278.68

mg/l

2.29

621

1759

Anxiety disorders

739

2466

2.14

75.07

1.1

232.45

268.85

mg/l

3.49

637

2176

Paralytic strabismus

101

128

8.16

74.78

1.1

366.20

282.75

mg/l

0.33

107

Convulsions, not elsewhere classified

227

593

3.83

74.19

1.1

229.26

271.15

mg/l

2.57

199

527

Other antidepressants

785

1924

2.14

74.04

1.1

254.12

277.22

mg/l

1.27

680

1711

Neurotic, stress-related and somatoform disorders

732

2459

2.13

73.75

1.1

231.94

267.78

mg/l

3.38

632

2171

Lower back pain or/and sciatica

771

2587

2.08

72.66

1.1

256.81

263.88

mg/l

0.35

681

2264

Depression

754

2510

2.08

71.06

1.1

240.43

270.31

mg/l

2.19

654

2213

Infections, IBD-co-morbidities

9.80

70.40

1.1

1.0

394.64

225.43

mg/l

1.16

Lyme disease

230

642

3.64

69.85

1.1

340.81

254.57

mg/l

4.69

219

555

Other spirochaetal diseases

232

654

3.60

69.42

1.1

340.67

254.28

mg/l

4.76

221

567

Mood [affective] disorders

782

2554

2.03

67.93

1.1

241.16

273.37

mg/l

2.52

677

2253

Mood disorders

782

2553

2.02

67.72

1.1

241.16

273.37

mg/l

2.52

677

2253

Implicit Sepsis

495

1616

2.40

67.35

1.1

269.81

278.91

mg/l

0.21

439

1428

Myalgia

227

645

3.57

67.12

1.1

234.93

240.55

mg/l

0.21

206

553

Cerebrovascular diseases

446

1268

2.54

67.08

1.1

294.37

300.91

mg/l

0.16

382

1114

Pain (limb, back, neck, head abdominally)

531

1094

2.45

66.84

1.1

253.75

279.05

mg/l

1.39

476

951

Any reimbursement code in KELA

568

1220

2.35

65.62

1.1

243.93

243.29

mg/l

0.02

494

1086

Soft tissue disorders

804

2076

2.02

65.56

1.1

240.70

265.13

mg/l

1.97

723

1811

Bell's palsy

138

277

5.09

64.84

1.1

344.12

260.70

mg/l

1.27

117

243

Opioids

777

2038

2.01

62.75

1.1

245.26

260.84

mg/l

0.94

671

1791

STROKE

414

1150

2.52

60.75

1.1

286.84

287.72

mg/l

0.02

351

1018

Recurrent or chronic depression

359

974

2.69

60.53

1.1

251.07

261.99

mg/l

0.26

316

871

Fever of other and unknown origin

352

1262

2.60

59.40

1.1

271.35

268.10

mg/l

0.08

316

1118

First line medication for Crohn's disease

827

2360

1.92

59.28

1.1

265.21

257.92

mg/l

0.20

728

2073

Oral corticosteroids

763

2375

1.95

58.94

1.1

256.86

272.04

mg/l

0.79

661

2088

Migraine without aura

220

667

3.35

58.89

1.1

222.33

223.18

mg/l

0.02

198

589

Disorders of thyroid, IBD co-morbidities

7.27

57.92

1.1

238.68

204.36

mg/l

0.93

Extrapyramidal and movement disorders

242

792

3.09

56.90

1.1

246.65

281.08

mg/l

1.97

209

698

Other and unspecified visual disturbances

113

214

5.41

56.80

1.1

206.35

264.37

mg/l

2.86

101

178

Other intervertebral disc disorders

556

1578

2.17

56.78

1.1

275.81

267.41

mg/l

0.25

502

1373

Persons encountering health services for examination and investigation

461

963

2.41

56.60

1.1

255.04

264.99

mg/l

0.42

407

830

Focal epilepsy, strict definition

187

525

3.62

56.40

1.1

261.14

264.81

mg/l

0.09

173

459

Examination and observation for other reasons

394

954

2.53

56.34

1.1

229.15

265.06

mg/l

3.19

368

823

Focal epilepsy

200

588

3.45

56.18

1.1

260.82

260.30

mg/l

0.01

182

515

Psychiatric diseases

760

1975

1.94

54.58

1.1

242.84

277.86

mg/l

3.34

666

1742

Speech disturbances, not elsewhere classified

169

5.94

54.44

1.1

1.0

282.62

288.05

mg/l

0.07

141

Systemic connective tissue disorders

259

906

2.89

54.14

1.1

248.59

257.57

mg/l

0.32

222

800

Inflammatory bowel disease treatment related agents

821

2520

1.86

54.03

1.1

249.38

267.71

mg/l

1.25

716

2216

Strabismus

258

904

2.89

53.68

1.1

280.17

248.43

mg/l

0.34

215

800

Sciatica+with lumbago

346

1329

2.49

53.53

1.1

267.03

269.70

mg/l

0.07

305

1161

Focal epilepsy, mode (most common among epilepsy diagnosis)

180

514

3.56

52.96

1.2

1.1

262.67

260.02

mg/l

0.06

164

448

Sarcoidosis

138

328

4.29

52.71

1.1

308.72

278.03

mg/l

0.50

120

282

Ischaemic Stroke, excluding all haemorrhages

300

841

2.71

52.45

1.1

282.89

309.40

mg/l

1.18

253

737

Stroke, excluding SAH

322

920

2.62

52.24

1.1

290.09

311.94

mg/l

0.74

270

803

Certain disorders involving the immune mechanism

180

523

3.50

51.61

1.2

1.1

292.91

270.54

mg/l

0.45

161

457

Neuromuscular dysfunction of bladder

103

199

5.30

50.65

1.1

351.60

289.92

mg/l

0.36

166

Anxiety (asthma-related co-morbidities)

508

1922

2.10

50.61

1.1

220.82

253.87

mg/l

2.52

447

1695

Depression or dysthymia

470

1184

2.23

50.36

1.1

262.60

286.45

mg/l

0.91

405

1063

Stroke, including SAH

334

1005

2.47

48.35

1.1

290.42

305.33

mg/l

0.47

282

881

Persons encountering health services for specific procedures and health care

752

2554

1.83

48.33

1.1

272.35

262.31

mg/l

0.31

647

2255

Codeine

686

1988

1.91

48.29

1.1

247.84

261.67

mg/l

0.76

594

1747

Lumbar disc prolapse

413

1484

2.23

47.85

1.1

266.84

270.69

mg/l

0.10

369

1291

Any mental disorder

746

2020

1.86

47.51

1.1

243.69

278.07

mg/l

3.20

654

1781

Tramadol

527

1660

2.05

47.43

1.1

279.77

272.11

mg/l

0.23

458

1456

Other disorders of lacrimal gland

253

943

2.71

46.99

1.1

257.70

252.77

mg/l

0.15

223

810

Depression medications

309

584

2.68

46.81

1.1

1.0

231.48

220.11

mg/l

0.50

267

521

Diseases of the musculoskeletal system and connective tissue

444

1001

2.24

46.35

1.1

233.67

257.05

mg/l

0.95

390

873

Diagnoses used for exclusion with ILD

184

586

3.17

45.47

1.1

338.12

283.37

mg/l

0.61

161

511

All anxiety disorders

513

2077

2.00

45.25

1.1

220.26

249.78

mg/l

2.22

452

1838

Spondylopathies

461

1328

2.12

44.54

1.1

299.68

279.35

mg/l

0.65

400

1157

Use of glatiramer acetate

10.98

44.50

1.0

1.1

222.30

227.10

mg/l

0.07

Symptoms and signs involving the circulatory and respiratory systems

758

2114

1.81

44.23

1.1

243.16

267.51

mg/l

0.92

666

1868

Symptoms and signs involving speech and voice

230

851

2.73

43.38

1.1

249.40

263.37

mg/l

0.50

208

745

Migraine with aura and triptan purchases

174

557

3.18

42.82

1.1

207.18

224.84

mg/l

0.87

159

485

Other/unspecified dorsalgia

252

978

2.58

42.67

1.1

236.07

250.14

mg/l

0.73

222

849

Certain infectious and parasitic diseases

700

1936

1.82

41.84

1.1

265.46

244.22

mg/l

1.25

625

1692

Dysphagia

161

499

3.26

41.66

1.1

369.15

277.65

mg/l

1.11

144

432

Disorders of lacrimal system

282

1175

2.42

41.56

1.1

260.66

259.23

mg/l

0.04

251

1020

Other extrapyramidal and movement disorders in other diseases

159

492

3.27

41.30

1.1

236.10

278.96

mg/l

1.95

139

427

Other disorders of eye and adnexa

141

406

3.53

41.14

1.1

251.50

246.19

mg/l

0.11

134

349

GASTRO-related operations

615

1650

1.88

40.69

1.1

248.94

247.31

mg/l

0.05

540

1458

Any gastric operation

615

1650

1.88

40.69

1.1

248.94

247.31

mg/l

0.05

540

1458

Parasetamol

607

1662

1.87

39.97

1.1

245.83

265.09

mg/l

1.02

530

1472

Other specific joint derangements/joint disorders

559

2007

1.88

39.56

1.1

241.11

256.55

mg/l

0.80

498

1754

Cardiovascular diseases

566

1632

1.90

39.54

1.1

230.88

238.41

mg/l

0.30

511

1433

Hemiplegia

106

6.40

39.48

1.2

1.1

237.89

244.13

mg/l

0.13

Ocular pain

223

4.41

37.97

1.1

251.19

251.31

mg/l

0.00

186

Syncope and collapse

238

837

2.53

37.95

1.1

239.03

282.79

mg/l

2.90

213

749

Visual field defects

165

4.94

36.57

1.1

265.83

274.27

mg/l

0.14

144

Other anxiety disorders

386

1698

2.03

36.24

1.1

225.18

243.58

mg/l

0.81

336

1502

Abnormalities of breathing

624

2096

1.78

36.17

1.1

240.49

267.44

mg/l

2.49

541

1850

Fibromyalgia

228

4.25

35.99

1.1

198.61

221.14

mg/l

1.25

198

Disorders of vestibular function (Vertigo)

267

1151

2.32

35.87

1.1

243.30

273.10

mg/l

2.37

236

1008

Other systemic involvement of connective tissue (FG)

175

617

2.84

35.76

1.1

224.49

254.84

mg/l

1.82

149

533

Spondylosis

277

1042

2.29

35.24

1.1

292.62

292.22

mg/l

0.01

238

902

Viral infections of the central nervous system

211

4.37

35.21

1.3

1.1

318.10

262.88

mg/l

1.17

180

Other general symptoms and signs

6.27

35.14

1.1

1.0

209.08

225.21

mg/l

0.42

Cervicalgia

142

456

3.15

34.74

1.1

297.12

248.42

mg/l

0.99

124

396

Somatoform disorder

147

484

3.08

34.54

1.1

213.22

252.79

mg/l

2.99

120

423

Use of peginterferon beta-1a

74.84

34.44

1.1

185.75

254.43

mg/l

—

Codeine or tramadol medication

749

2494

1.67

34.35

1.1

256.58

266.83

mg/l

0.45

654

2184

Parkinson's disease, excluding more controls

7.51

34.09

1.2

1.0

270.95

286.07

mg/l

0.17

Parkinson's disease, strict definition, excluding more controls

7.97

33.72

1.2

1.0

272.70

289.62

mg/l

0.18

ILD differential diagnosis

550

1512

1.83

33.68

1.1

252.72

263.69

mg/l

0.56

483

1321

Cervicobrachial syndrome

158

549

2.91

33.68

1.1

241.36

246.14

mg/l

0.12

148

473

COPD differential diagnosis

550

1513

1.83

33.62

1.1

252.72

263.80

mg/l

0.57

483

1322

Migraine without aura and triptan purchases

170

618

2.79

33.42

1.1

230.65

221.37

mg/l

0.18

153

545

Pain in throat and chest

562

1935

1.78

33.23

1.1

262.11

274.35

mg/l

0.27

491

1707

Hypothyroidism, strict autoimmune

407

1376

1.97

33.13

1.1

241.46

262.38

mg/l

1.02

358

1209

Chorioretinal inflammation

8.16

32.56

1.2

1.1

238.03

231.57

mg/l

0.11

Symptoms and signs involving the urinary system

432

1773

1.89

32.42

1.1

306.92

272.84

mg/l

0.86

382

1568

Radiculopathy

104

287

3.66

32.36

1.1

286.57

268.08

mg/l

0.35

246

Symptoms and signs involving the digestive system and abdomen

654

1919

1.71

32.28

1.1

272.30

268.49

mg/l

0.08

579

1693

Oedema, not elsewhere classified

162

580

2.80

32.28

1.1

253.92

274.39

mg/l

0.52

137

522

Other and unspecified nerve root and plexus disorders, also in other diseases

141

472

3.02

32.19

1.1

290.02

269.52

mg/l

0.26

123

418

Antihypertensive medication - note that there are other indications

540

1650

1.80

32.09

1.1

227.64

248.11

mg/l

1.06

475

1454

Excluding asthma or asthma-COPD overlap

544

1515

1.81

32.02

1.1

251.28

263.62

mg/l

0.65

477

1323

Diseases of the myoneural junction and muscle

263

3.78

31.84

1.1

376.00

297.11

mg/l

0.84

224

Other systemic involvement of connective tissue

180

693

2.62

31.54

1.1

224.49

249.94

mg/l

1.66

154

613

Cardiovascular diseases (excluding rheumatic etc)

547

1789

1.78

31.46

1.1

240.20

240.44

mg/l

0.01

486

1572

Temporomandibular joint disorders

117

359

3.29

30.93

1.0

1.1

220.08

248.75

mg/l

1.22

304

Other pulmonary diagnosis

538

1515

1.79

30.58

1.1

247.85

263.62

mg/l

0.96

471

1323

Cervical disc disorders

200

829

2.43

29.97

1.1

261.73

279.73

mg/l

0.45

178

717

Other disorders of binocular movement

7.24

29.92

1.1

218.73

239.61

mg/l

0.26

Migraine, single triptan purchase ok & required. ICD-code if available is included

562

2227

1.72

29.84

1.1

225.56

257.76

mg/l

2.73

495

1954

Triptan medication for migraine, single purchase ok

562

2227

1.72

29.84

1.1

225.56

257.76

mg/l

2.73

495

1954

Asthma, excluding more controls

498

1476

1.81

29.83

1.1

238.34

263.54

mg/l

1.64

437

1286

Sixth [abducent] nerve palsy

7.33

29.82

1.1

206.75

249.17

mg/l

1.11

Hard cardiovascular diseases

409

1390

1.90

29.81

1.1

280.62

300.98

mg/l

0.88

346

1221

Polyuria

139

482

2.91

29.81

1.1

252.42

292.63

mg/l

1.66

120

422

Factors influencing health status and contact with health services

198

376

2.66

29.74

1.1

286.20

272.05

mg/l

0.34

172

326

Diseases of inner ear

291

1382

2.07

29.63

1.1

241.73

276.48

mg/l

3.34

258

1218

Enlarged lymph nodes

112

344

3.29

29.59

1.2

1.1

266.66

273.17

mg/l

0.11

308

Non-invasive ventilation

159

555

2.71

29.53

1.1

300.69

266.78

mg/l

0.27

129

497

Sleep disorders (combined)

608

2385

1.68

29.52

1.1

266.17

274.09

mg/l

0.31

525

2109

Hypothyroidism (congenital or acquired)

228

548

2.41

29.35

1.1

1.0

232.39

219.19

mg/l

0.45

197

488

Asthma

499

1500

1.79

29.19

1.1

238.40

263.48

mg/l

1.65

438

1309

Follow-up examination after treatment for conditions other than malignant neoplasms

258

762

2.23

29.04

1.1

261.93

257.33

mg/l

0.05

228

655

Implicit viral Sepsis

124

410

3.05

28.96

1.2

1.1

284.57

276.08

mg/l

0.15

110

353

Viral Sepsis

124

412

3.04

28.72

1.2

1.1

284.57

275.83

mg/l

0.16

110

354

Organic, including symptomatic, mental disorders

203

604

2.44

28.64

1.1

264.75

318.13

mg/l

3.27

169

535

Asthma (mode)

490

1512

1.79

28.61

1.1

237.42

263.69

mg/l

1.75

426

1321

Coxibs

206

438

2.52

28.51

1.1

240.69

288.38

mg/l

1.36

177

378

Symptoms and signs concerning food and fluid intake

171

4.32

28.50

1.1

1.0

275.97

276.71

mg/l

0.01

150

Nausea and vomiting

168

649

2.56

28.19

1.1

304.81

249.16

mg/l

0.42

145

566

Other diseases of spinal cord

7.23

28.13

1.2

1.1

264.06

250.56

mg/l

0.18

Other necrotizing vasculopathies (FG)

5.70

27.91

1.1

252.52

298.23

mg/l

0.78

Hypothyroidism, levothyroxine purchases

223

546

2.37

27.70

1.1

1.0

227.44

218.69

mg/l

0.27

192

486

Hypothyroidism and >3 levothyroxin purchases

223

546

2.37

27.70

1.1

1.0

227.44

218.69

mg/l

0.27

192

486

Alzheimer disease, excluding more controls

6.26

27.61

1.0

1.1

295.53

316.98

mg/l

0.16

Other reaction to severe stress, and adjustment disorders

293

1467

2.01

27.57

1.1

235.56

239.13

mg/l

0.12

250

1291

Disorders of eyelid, lacrimal system and orbit

480

2174

1.74

27.54

1.1

264.66

269.78

mg/l

0.19

428

1902

Diseases of the ear and mastoid process

770

2491

1.57

27.18

1.1

242.50

269.48

mg/l

2.40

686

2177

Primary_lymphoid and hematopoietic malignant neoplasms

133

475

2.82

27.02

1.2

1.1

386.59

284.18

mg/l

1.77

116

424

Other joint disorders

628

2045

1.64

26.95

1.1

234.99

258.22

mg/l

1.93

564

1791

Disorders of refraction and accommodation

207

911

2.28

26.93

1.1

217.91

242.79

mg/l

1.31

173

808

Other diseases of urinary system

633

2192

1.63

26.78

1.1

261.50

259.04

mg/l

0.06

544

1935

Primary_lymphoid and hematopoietic malignant neoplasms

133

486

2.76

25.93

1.2

1.1

386.59

285.62

mg/l

1.73

116

423

ILD medications: azathioprine

119

413

2.91

25.59

1.2

1.1

286.06

255.32

mg/l

0.73

101

372

Selective serotonin reuptake inhibitors

598

1932

1.63

25.24

1.1

250.92

276.55

mg/l

1.64

529

1719

Sequelae of cerebrovascular disease

150

513

2.58

25.01

1.1

281.10

304.98

mg/l

0.72

133

453

Status epilepticus

6.61

24.81

1.2

1.0

281.59

278.57

mg/l

0.02

Anaemias

178

490

2.43

24.51

1.1

1.0

261.67

225.32

mg/l

0.78

143

436

Other strabismus

175

749

2.35

24.43

1.1

227.29

244.72

mg/l

0.62

150

667

Spinal stenosis

205

721

2.24

24.43

1.1

358.61

299.68

mg/l

1.50

178

621

Meningitis

134

4.51

24.15

1.1

480.02

270.20

mg/l

2.13

112

Special screening examination for infectious and parasitic diseases

194

637

2.29

24.13

1.1

249.73

244.78

mg/l

0.13

182

551

Asthma (only as main-diagnosis)

432

1500

1.74

23.88

1.1

222.71

263.48

mg/l

4.97

378

1309

Persons encountering health services in other circumstances, wide

726

2461

1.54

23.54

1.1

274.00

266.01

mg/l

0.22

636

2163

Asthma (only as main-diagnosis), excluding more controls

429

1476

1.74

23.38

1.1

222.66

263.54

mg/l

4.90

375

1286

Trigeminal neuralgia

110

4.81

23.18

1.2

1.1

262.26

238.56

mg/l

0.27

Other disorders of urethra and urinary system

406

1758

1.74

23.17

1.1

258.58

253.36

mg/l

0.09

353

1544

Abdominal and pelvic pain

607

1918

1.60

23.09

1.1

264.67

268.60

mg/l

0.10

544

1692

Arthropathies

634

2052

1.58

23.05

1.1

239.85

257.78

mg/l

1.18

559

1797

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

112

4.74

22.72

1.1

623.27

261.26

mg/l

1.08

100

Other necrotizing vasculopathies

128

4.45

22.70

1.1

261.02

280.90

mg/l

0.31

114

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

7.85

22.21

1.1

1.0

273.40

269.68

mg/l

0.03

Dissociative [conversion] disorders

127

4.45

22.11

1.1

190.36

219.98

mg/l

1.15

108

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

157

4.01

21.98

1.1

599.94

265.00

mg/l

1.26

136

Pain in thoracic spine

104

366

2.87

21.87

1.1

210.79

245.61

mg/l

2.06

316

Oxycodone

165

705

2.28

21.41

1.1

375.18

302.14

mg/l

0.95

142

620

Cough

232

1123

1.99

21.32

1.1

222.49

270.05

mg/l

3.90

203

993

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

204

986

2.08

21.29

1.1

227.60

241.69

mg/l

0.60

182

875

Irritable bowel syndrome

192

908

2.13

21.23

1.1

262.79

247.24

mg/l

0.35

169

784

Other disorders of nervous system

127

4.32

21.14

1.3

1.0

401.21

276.44

mg/l

1.05

107

Implicit bacterial Sepsis

164

665

2.27

21.01

1.1

348.76

302.33

mg/l

0.43

137

581

Other mental disorders due to brain damage and dysfunction and to physical disease

172

3.76

20.86

1.1

1.0

270.12

311.93

mg/l

1.08

149

Acute upper respiratory infections

610

2493

1.54

20.79

1.1

244.18

269.45

mg/l

1.87

525

2199

Brachial plexus disorders

277

3.11

20.56

1.2

1.1

312.68

251.02

mg/l

0.54

247

Persons encountering health services for other counselling and medical advice, not elsewhere classified

652

2457

1.52

20.54

1.1

279.81

265.96

mg/l

0.37

583

2159

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

548

2527

1.56

20.40

1.1

290.63

263.79

mg/l

0.78

464

2240

Dyspnoea

484

2324

1.60

20.37

1.1

239.21

275.30

mg/l

3.83

426

2036

Heterophoria

244

3.25

20.22

1.1

205.98

234.54

mg/l

0.90

209

Other and unspecified dermatitis

294

1635

1.81

20.21

1.1

278.37

256.48

mg/l

0.44

259

1445

Dermatitis

340

1972

1.73

20.19

1.1

276.68

264.74

mg/l

0.24

301

1740

Finngen Rheumatological endpoints

623

2340

1.52

19.96

1.1

240.10

263.26

mg/l

1.90

551

2049

Azathioprine

119

471

2.55

19.95

1.2

1.1

286.06

261.73

mg/l

0.53

101

419

Transient ischemic attack

207

843

2.04

19.94

1.1

286.71

302.68

mg/l

0.47

180

735

Lesion of lateral popliteal nerve

108

4.53

19.91

1.2

1.1

304.71

282.16

mg/l

0.10

Cystitis

496

1917

1.59

19.36

1.1

263.01

249.31

mg/l

0.29

429

1688

Abnormal findings on diagnostic imaging of lung

190

901

2.06

19.34

1.1

295.99

299.50

mg/l

0.09

170

786

Other meningitis

7.49

19.21

1.1

332.52

215.29

mg/l

1.34

Asthma, unspecified (mode)

290

1279

1.80

19.15

1.1

234.86

269.28

mg/l

2.13

247

1123

Asthma, unspecified (mode), excluding more controls

289

1262

1.81

19.08

1.1

233.15

269.41

mg/l

2.32

246

1105

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

243

3.16

18.97

1.2

1.0

485.14

283.61

mg/l

2.24

214

Visual impairment including blindness (binocular or monocular)

125

4.14

18.94

1.2

1.1

283.39

251.41

mg/l

0.52

107

Cervicocranial syndrome

235

3.18

18.70

1.1

279.86

242.12

mg/l

0.48

204

Gastrointestinal diseases

443

1365

1.63

18.55

1.1

231.62

259.36

mg/l

1.73

387

1200

Other symptoms and signs involving the urinary system

216

3.28

18.55

1.2

1.1

303.40

284.13

mg/l

0.14

181

Intracranial injury

323

1827

1.72

18.51

1.1

258.91

264.63

mg/l

0.08

276

1614

Lesion of ulnar nerve

322

2.82

18.44

1.1

282.33

284.67

mg/l

0.02

282

Provisional assignment of new diseases of uncertain etiology

289

1648

1.76

18.31

1.1

288.06

242.27

mg/l

0.79

255

1444

Codes for special purposes

289

1649

1.76

18.27

1.1

288.06

242.26

mg/l

0.79

255

1445

106

415

2.58

18.23

1.1

233.44

244.55

mg/l

0.28

361

Shoulder lesions

391

1453

1.65

18.04

1.1

276.64

283.14

mg/l

0.17

353

1269

Hypertensive diseases (excluding secondary)

361

1244

1.69

18.01

1.1

274.87

252.80

mg/l

1.01

317

1097

Bacterial Sepsis

186

817

2.03

17.99

1.1

348.08

294.84

mg/l

0.61

156

716

Triptan medication for migraine, min. 3 purchases

407

1997

1.62

17.95

1.1

219.53

233.87

mg/l

0.67

363

1745

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

294

1660

1.74

17.85

1.1

265.20

274.48

mg/l

0.27

258

1441

Malignant neoplasm of brain

5.12

17.69

1.0

1.1

694.74

273.47

mg/l

0.84

Dermatitis and eczema

633

2833

1.47

17.61

1.1

262.34

265.26

mg/l

0.08

548

2496

Bacterial infection, other or unspecified

241

1182

1.85

17.59

1.1

348.32

278.72

mg/l

1.12

203

1043

Other sleep disorders

237

3.07

17.16

1.1

1.0

250.19

287.26

mg/l

0.75

203

Acute upper respiratory infections of multiple and unspecified sites

457

2211

1.55

17.00

1.1

262.29

254.36

mg/l

0.16

400

1948

Benzodiazepine use

568

2731

1.48

16.92

1.1

251.99

269.13

mg/l

0.70

486

2405

Bronchitis

612

2750

1.46

16.74

1.1

244.16

265.77

mg/l

1.62

529

2418

Alzheimer’s disease, wide definition, excluding more controls

5.22

16.74

1.0

1.1

313.18

334.91

mg/l

0.13

Other disorders of fluid, electrolyte and acid-base balance

133

576

2.24

16.72

1.1

296.98

284.32

mg/l

0.26

115

505

Other diseases of upper respiratory tract

626

2229

1.47

16.65

1.1

259.63

272.81

mg/l

0.64

560

1936

Atypical facial pain

103

4.25

16.51

1.1

1.0

214.21

235.03

mg/l

0.55

Abnormalities of heart beat

195

1008

1.93

16.50

1.1

225.90

265.08

mg/l

3.15

169

887

Delirium, not induced by alcohol and other psychoactive substances

152

3.58

16.48

1.1

1.0

269.08

304.19

mg/l

0.51

129

Any dementia, excluding more controls

102

274

2.59

16.45

1.1

263.70

337.82

mg/l

2.58

240

Sleep apnoea

476

2113

1.53

16.39

1.1

278.93

279.59

mg/l

0.02

409

1866

Degenerative diseases of the nervous system

288

2.60

16.36

1.1

326.89

330.01

mg/l

0.02

251

Gastro-oesophageal reflux disease

354

1948

1.62

16.00

1.1

268.21

280.79

mg/l

0.31

319

1717

Exclusions for E4_PCOS_BROAD

123

549

2.26

15.86

1.1

271.79

249.58

mg/l

0.27

479

Use of pramipexole

108

456

2.38

15.83

1.2

1.1

258.71

282.63

mg/l

0.57

396

Dementia, including avohilmo

136

423

2.23

15.78

1.1

264.15

326.98

mg/l

3.22

114

372

Other external causes of accidental injury

519

1729

1.51

15.62

1.1

258.45

260.18

mg/l

0.05

453

1514

Diseases of the respiratory system

395

1237

1.60

15.60

1.1

253.26

263.59

mg/l

0.38

344

1086

Retention of urine

141

560

2.14

15.49

1.1

361.87

303.00

mg/l

0.52

125

486

Nonorganic sleeping disorders, excluding more controls

120

546

2.21

14.81

1.1

214.64

250.27

mg/l

2.06

108

484

Diseases of oesophagus, stomach and duodenum

594

2516

1.44

14.71

1.1

261.43

267.90

mg/l

0.21

519

2212

Acute sinusitis

330

1925

1.60

14.67

1.1

236.21

251.76

mg/l

0.82

284

1696

Optic atrophy

6.52

14.64

1.1

239.58

197.19

mg/l

0.68

Dementia

123

380

2.24

14.58

1.1

251.62

326.05

mg/l

4.40

102

340

Obesity related asthma

186

998

1.87

14.55

1.1

241.75

266.50

mg/l

1.60

156

876

Temporomandibular joint disorders, including avohilmo

290

1764

1.65

14.55

1.1

226.21

226.36

mg/l

0.01

249

1534

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

4.86

14.52

1.2

1.0

476.69

258.42

mg/l

1.33

Cluster headache, strict

4.62

14.51

1.2

1.1

252.90

264.06

mg/l

0.15

Other functional intestinal disorders

227

1230

1.76

14.50

1.1

286.15

261.27

mg/l

0.58

185

1074

Vocal cord dysfunction

304

2.58

14.44

1.1

274.89

270.31

mg/l

0.07

270

Endocrine, nutritional and metabolic diseases

551

1922

1.46

14.41

1.1

255.46

256.46

mg/l

0.03

481

1708

Diseases of pulp and periapical tissues

197

1080

1.83

14.39

1.1

258.64

288.76

mg/l

1.24

178

955

Asthma, including avohilmo

673

2797

1.40

14.34

1.1

235.81

270.96

mg/l

3.58

577

2468

Rheumatism, unspecified

291

2.67

14.30

1.1

255.09

251.65

mg/l

0.03

251

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

4.55

14.27

1.1

350.59

265.53

mg/l

1.24

634

2365

1.42

14.23

1.1

245.33

270.14

mg/l

1.87

545

2085

Complications of medical and surgical care

369

2271

1.55

14.11

1.1

263.21

267.14

mg/l

0.06

324

1998

Intestinal infectious diseases

528

2850

1.45

14.07

1.1

268.74

261.41

mg/l

0.16

460

2504

Accidents

509

1729

1.48

14.01

1.1

258.37

260.18

mg/l

0.05

444

1514

Functional dyspepsia

151

766

1.98

13.99

1.0

1.1

249.36

259.49

mg/l

0.23

133

674

Other symptoms and signs involving the circulatory and respiratory systems

155

3.33

13.95

1.1

380.13

300.24

mg/l

0.23

127

Benign neoplasm of meninges

181

3.12

13.85

1.1

335.22

245.93

mg/l

1.24

160

Cluster headache, wide

4.43

13.83

1.2

1.1

252.90

259.32

mg/l

0.08

Abnormal findings on diagnostic imaging of other body structures

257

2.75

13.78

1.2

1.1

277.13

264.96

mg/l

0.21

226

Chronic diseases of tonsils and adenoids

485

2090

1.47

13.76

1.1

244.51

265.71

mg/l

1.14

434

1816

Metatarsalgia

203

2.99

13.72

1.1

261.63

250.49

mg/l

0.17

172

Personality disorders, excluding more controls

170

906

1.89

13.63

1.1

197.88

244.93

mg/l

6.76

148

806

Hypo-osmolality and hyponatraemia

286

2.63

13.60

1.1

319.60

283.13

mg/l

0.62

247

Disorders of sclera, cornea, iris and ciliary body

296

1844

1.61

13.59

1.1

281.06

260.23

mg/l

0.64

252

1637

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.58

13.57

1.2

1.1

476.69

259.52

mg/l

1.33

Asthma (diagnoses ohter than nonallergic)

478

2817

1.45

13.40

1.1

229.40

268.70

mg/l

4.14

417

2479

Benign paroxysmal vertigo

134

662

2.04

13.39

1.1

256.24

268.02

mg/l

0.35

119

578

Any dementia

104

318

2.31

13.34

1.1

264.59

322.50

mg/l

1.90

275

Asthma, hospital admission 2, infections

314

1959

1.58

13.33

1.1

237.04

259.10

mg/l

1.18

270

1728

Asthma-related infections

314

1959

1.58

13.33

1.1

237.04

259.10

mg/l

1.18

270

1728

Chronic sinusitis

240

1426

1.69

13.26

1.1

254.38

258.84

mg/l

0.12

211

1240

Metabolic disorders

487

2077

1.46

13.21

1.1

268.60

277.01

mg/l

0.34

424

1834

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

126

3.53

13.20

1.2

1.0

332.46

268.18

mg/l

1.06

113

Restless leg syndrome

286

2.61

13.20

1.1

235.45

265.97

mg/l

0.67

249

COPD/asthma related infections

605

2150

1.41

13.14

1.1

249.75

261.89

mg/l

0.61

527

1897

COPD/asthma/ILD related infections

605

2150

1.41

13.14

1.1

249.75

261.89

mg/l

0.61

527

1897

Benign neoplasm: Cerebral meninges

167

3.15

13.02

1.1

313.46

242.38

mg/l

0.95

149

Viral meningitis

109

3.75

12.97

1.2

1.0

343.60

244.49

mg/l

1.40

Malignant neoplasm of eye, brain and central nervous system

100

3.87

12.93

1.0

1.1

685.84

282.14

mg/l

0.83

Non-follicular lymphoma, hilmo, excluding all cancers

168

3.13

12.89

1.2

1.0

424.57

270.84

mg/l

1.70

148

258

1570

1.64

12.64

1.1

233.07

249.10

mg/l

0.62

220

1380

Voice disturbances

138

708

1.96

12.44

1.1

230.47

257.55

mg/l

1.31

126

617

Other disorders of bladder

226

2.77

12.41

1.1

271.87

317.43

mg/l

0.85

192

Rotator cuff syndrome

269

1232

1.63

12.32

1.0

1.1

279.16

293.27

mg/l

0.48

246

1074

Other enthesopathy of foot (+metatarsalgia)

227

2.76

12.32

1.0

1.1

261.96

249.87

mg/l

0.19

192

Dislocation, sprain and strain of joints and ligaments at neck level

118

577

2.06

12.22

1.1

223.76

241.67

mg/l

0.56

107

508

Disorders of muscles

223

2.76

12.16

1.1

408.02

271.93

mg/l

0.54

188

Falls/tendency to fall

662

2424

1.37

12.11

1.1

255.44

259.34

mg/l

0.15

580

2132

Other shoulder lesions

218

2.78

12.10

1.1

286.34

262.45

mg/l

0.23

182

Viral infections characterized by skin and mucous membrane lesions

230

1386

1.67

12.10

1.1

278.64

258.49

mg/l

0.72

208

1232

Non-follicular lymphoma

175

3.00

12.05

1.2

1.0

424.57

296.89

mg/l

1.25

151

Hypertension, essential

438

1708

1.47

12.03

1.1

275.12

273.66

mg/l

0.04

378

1509

Other diseases of intestines

619

2618

1.38

12.03

1.1

250.88

261.69

mg/l

0.48

548

2298

Sleep apnoea, including avohilmo

498

2273

1.43

12.03

1.1

280.66

277.33

mg/l

0.10

430

2010

Genitourinary diseases

378

1250

1.52

12.00

1.1

254.86

271.91

mg/l

0.69

337

1100

Enthesopathies of lower limb, excluding foot

114

554

2.07

11.98

1.1

271.19

249.61

mg/l

0.48

105

478

Injuries to the head

605

2870

1.38

11.93

1.1

282.62

260.35

mg/l

0.68

523

2526

Benign neoplasm of meninges

199

2.84

11.78

1.1

335.22

260.69

mg/l

0.94

174

Unknown and unspecified causes of morbidity

141

3.22

11.76

1.2

1.0

235.49

278.81

mg/l

0.95

128

Other symptoms and signs involving the digestive system and abdomen

370

2.31

11.76

1.1

297.71

243.64

mg/l

0.68

327

External causes of morbidity and mortality

422

1434

1.48

11.73

1.1

249.27

263.31

mg/l

0.49

360

1253

Acetic acid derivatives and related substances

158

431

1.92

11.71

1.1

265.03

289.84

mg/l

0.46

140

371

Disorders of other endocrine glands

238

1436

1.64

11.70

1.1

255.47

246.77

mg/l

0.15

198

1273

Exposure to unspecified factor

530

2956

1.39

11.66

1.1

287.76

260.09

mg/l

0.78

457

2603

Chronic lower respiratory diseases

688

2770

1.35

11.44

1.1

253.47

266.94

mg/l

0.45

597

2439

Fall on same level

664

2749

1.35

11.44

1.1

261.58

260.69

mg/l

0.03

577

2421

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

237

2.64

11.38

1.1

233.19

268.37

mg/l

0.88

208

Constipation

412

2035

1.45

11.29

1.1

282.07

272.12

mg/l

0.30

344

1800

Injuries to the neck

150

821

1.84

11.17

1.1

279.87

250.01

mg/l

0.26

137

720

Hypermetropia

200

2.78

11.12

1.1

207.50

249.36

mg/l

0.99

170

Covid-19 confirmed case

155

860

1.81

11.03

1.1

347.81

256.35

mg/l

0.87

129

753

Dystonia

122

3.32

10.96

1.2

1.1

209.94

246.44

mg/l

1.15

102

Sleep disorders

143

777

1.85

10.92

1.1

217.01

242.33

mg/l

1.40

126

681

Dentofacial anomalies [including malocclusion]

178

1020

1.74

10.91

1.0

1.1

222.08

243.00

mg/l

1.32

152

904

Adrenocortical insufficiency

3.95

10.87

1.2

1.1

422.00

239.09

mg/l

0.65

Hypermobility syndrome

192

2.80

10.83

1.0

201.32

211.34

mg/l

0.34

167

Transport accidents

266

1510

1.57

10.80

1.1

261.60

256.62

mg/l

0.06

238

1322

Osteopathies and chondropathies

261

1583

1.57

10.76

1.0

1.1

260.36

265.20

mg/l

0.12

217

1401

Undetermined asthma, excluding more controls

285

2.44

10.76

1.1

255.41

279.98

mg/l

0.44

248

Undetermined asthma

285

2.44

10.76

1.1

255.41

277.93

mg/l

0.40

249

Benign neoplasm: Cerebral meninges

187

2.81

10.74

1.1

313.46

253.13

mg/l

0.74

162

Injuries to the wrist and hand

546

2897

1.37

10.68

1.1

275.09

260.67

mg/l

0.37

477

2543

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

204

1235

1.66

10.66

1.1

227.60

233.95

mg/l

0.23

182

1091

Panic disorder

111

560

2.00

10.61

1.1

202.43

239.02

mg/l

2.11

100

493

Other diseases of hard tissues of teeth

354

1794

1.48

10.58

1.1

246.00

274.85

mg/l

1.76

297

1586

Cluster headache, strict, including avohilmo

146

3.06

10.53

1.3

1.1

246.71

258.59

mg/l

0.21

124

Cardiac arrhythmias

368

1661

1.47

10.52

1.1

232.12

251.98

mg/l

1.26

310

1482

Diseases of the skin and subcutaneous tissue

589

2174

1.36

10.44

1.1

259.27

259.30

mg/l

0.00

514

1932

Disorders of choroid and retina

342

1689

1.48

10.29

1.1

290.81

291.30

mg/l

0.01

291

1491

Other enthesopathies

146

814

1.80

10.26

1.1

286.11

257.63

mg/l

0.43

126

704

Disorders of the thyroid gland

510

2425

1.38

10.23

1.1

246.95

259.00

mg/l

0.65

447

2127

Persons encountering health services in other circumstances

209

1287

1.63

10.18

1.1

310.77

246.06

mg/l

0.80

172

1136

Other diseases of blood and blood-forming organs, wide

110

562

1.97

10.14

1.1

350.33

269.15

mg/l

0.54

490

Mixed connective tissue disease

160

2.91

10.13

1.1

252.25

250.04

mg/l

0.03

136

Asthma, hospital admissions , main diagnosis only

445

2863

1.40

10.11

1.1

223.32

268.21

mg/l

6.14

389

2514

Diarrhoea and gastroenteritis of presumed infectious origin

389

2483

1.43

10.08

1.1

245.31

255.01

mg/l

0.49

337

2175

Disorders of synovium and tendon

261

1525

1.55

10.06

1.1

258.07

268.72

mg/l

0.33

231

1334

Hypothyroidism, other/unspecified

479

2291

1.38

9.89

1.1

240.18

255.38

mg/l

0.89

418

2005

Zoster [herpes zoster]

367

2.19

9.84

1.3

1.1

311.96

272.32

mg/l

0.80

319

Cluster headache, wide,, including avohilmo

152

2.94

9.83

1.3

1.1

246.71

261.97

mg/l

0.29

129

Hypothyreosis and Thyroxine purchase for inclusion criteria

491

2360

1.38

9.83

1.1

241.16

255.74

mg/l

0.85

429

2068

Paracetamol of NSAID medication

114

285

2.02

9.80

1.1

251.32

290.38

mg/l

0.55

250

Non-selective monoamine reuptake inhibitors

160

904

1.72

9.64

1.1

256.57

273.50

mg/l

0.33

134

807

Neoplasms

513

2012

1.37

9.62

1.1

270.80

236.70

mg/l

0.96

452

1760

Use of levodopa decarboxylase inhibitor

193

2.66

9.58

1.2

1.1

362.45

317.48

mg/l

0.18

164

Dental caries

140

780

1.79

9.57

1.1

263.23

273.37

mg/l

0.22

123

691

Exposure to other specified factors

405

2717

1.40

9.54

1.1

270.12

261.86

mg/l

0.16

359

2380

Sicca syndrome [Sjögren]

188

2.68

9.53

1.2

1.1

205.00

241.84

mg/l

1.43

166

Astigmatism

166

2.80

9.48

1.1

176.70

236.35

mg/l

2.00

137

Internal derangement of knee

196

1211

1.62

9.39

1.0

1.1

256.92

271.68

mg/l

0.59

173

1063

Hypertensive diseases

440

1787

1.40

9.39

1.1

277.71

271.45

mg/l

0.20

381

1579

Faecal incontinence

156

2.84

9.37

1.0

1.1

265.26

247.99

mg/l

0.23

137

Explicit Sepsis

166

944

1.69

9.35

1.1

359.29

274.70

mg/l

0.98

138

833

Retinal detachments and breaks

129

714

1.81

9.33

1.1

309.96

288.72

mg/l

0.38

110

640

Vitamin deficiency, wide

104

3.31

9.32

1.1

210.66

222.54

mg/l

0.30

Vitamin deficiency

104

3.31

9.32

1.1

210.66

222.54

mg/l

0.30

Chronic laryngitis and laryngotracheitis

324

2.24

9.31

1.1

1.0

309.40

272.61

mg/l

0.40

277

Unspecific neurodegenerative disorder

333

2.03

9.31

1.1

275.91

329.71

mg/l

1.58

291

Unspecified dementia

3.55

9.29

1.0

257.04

299.98

mg/l

1.03

Use of hypnotics and sedatives

562

2432

1.34

9.26

1.1

259.54

272.21

mg/l

0.65

493

2136

Propionic acid derivatives

166

479

1.75

9.26

1.1

247.38

286.87

mg/l

0.93

143

418

All influenza

129

717

1.81

9.21

1.1

255.95

267.05

mg/l

0.30

117

631

Hypertension

438

1784

1.39

9.19

1.1

277.89

271.63

mg/l

0.20

380

1576

Other specified/unspecified systemic involvement of connective tissue

131

3.01

9.16

1.1

226.42

243.88

mg/l

0.27

115

Disorders of lens

271

1128

1.52

9.15

1.1

316.10

309.03

mg/l

0.11

233

989

Abnormal findings on examination of blood, without diagnosis

187

1080

1.63

9.02

1.0

1.1

256.71

302.08

mg/l

2.46

163

950

Other respiratory disorders and diseases

374

2.12

9.01

1.0

1.1

408.92

297.38

mg/l

0.53

326

Other diseases of the respiratory system

374

2.12

9.01

1.0

1.1

408.92

297.38

mg/l

0.53

326

Diseases of pulp and periapical tissues, including avohilmo

600

2358

1.32

9.01

1.1

244.21

272.57

mg/l

2.14

522

2080

Dental pulpitis 1

601

2363

1.32

9.00

1.1

244.58

272.67

mg/l

2.12

523

2084

Dental pulpitis 4

601

2363

1.32

8.99

1.1

244.58

272.67

mg/l

2.12

523

2084

Diseases of oral cavity, salivary glands and jaws

485

1823

1.37

8.97

1.1

251.18

275.28

mg/l

1.60

428

1612

Irregular menses

304

1691

1.46

8.92

1.1

209.10

219.77

mg/l

0.57

267

1474

Other and unspecified mononeuropathies, also in other diseases

4.38

8.89

1.2

1.1

239.00

243.26

mg/l

0.04

Other and unspecified drugs and medicaments

220

2.48

8.79

1.1

231.71

264.18

mg/l

0.73

188

Deforming dorsopathies

129

729

1.78

8.74

1.1

245.93

245.50

mg/l

0.01

105

624

Trochanteric bursitis

257

2.35

8.73

1.1

245.67

256.12

mg/l

0.16

224

Vestibular neuronitis

203

2.54

8.71

1.1

221.97

294.77

mg/l

2.75

171

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

197

1236

1.58

8.60

1.1

209.21

219.10

mg/l

0.53

165

1090

Other diseases of stomach and duodenum

120

3.03

8.58

1.1

1.0

225.75

302.22

mg/l

2.02

105

Abnormal weight loss

187

2.59

8.57

1.1

300.66

272.36

mg/l

0.26

162

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

277

1884

1.47

8.56

1.1

270.22

268.06

mg/l

0.03

242

1658

Dentinal caries

124

694

1.79

8.55

1.1

269.44

268.56

mg/l

0.02

112

614

Hypopituitarism

206

2.50

8.47

1.2

1.1

223.79

288.03

mg/l

1.78

173

Non-allergic asthma (mode)

435

1.99

8.37

1.1

257.76

271.80

mg/l

0.19

379

Injuries to the ankle and foot

399

2654

1.37

8.35

1.1

253.34

250.19

mg/l

0.09

341

2341

Carpal tunnel syndrome

256

1558

1.49

8.33

1.1

266.19

274.67

mg/l

0.29

229

1372

Emotional disorders starting during childhood or adolecense, excluding more controls

152

2.74

8.30

1.0

163.65

216.31

mg/l

2.01

125

Other specified/unspecified arthritis

135

786

1.72

8.28

1.1

348.04

260.28

mg/l

0.78

118

679

Non-allergic asthma (mode), excluding more controls

437

1.98

8.27

1.1

257.76

274.03

mg/l

0.22

381

Septicaemia

155

899

1.66

8.27

1.1

373.71

277.12

mg/l

1.10

130

801

Iridocyclitis

120

676

1.78

8.26

1.1

271.38

257.98

mg/l

0.19

102

596

Other viral diseases

187

1182

1.59

8.23

1.1

242.39

239.62

mg/l

0.06

164

1041

Soft tissue disorders related to use, overuse and pressure

110

604

1.83

8.23

1.1

258.19

271.37

mg/l

0.31

516

Osteoporosis

414

1.99

8.22

1.1

326.32

276.22

mg/l

0.66

367

Undefined dementia

3.25

8.20

1.0

1.1

257.04

287.40

mg/l

0.62

Pain and other conditions associated with female genital organs and menstrual cycle

147

842

1.68

8.18

1.1

196.34

206.00

mg/l

0.48

127

734

Hypothyroidism, drug reimbursement

310

2.02

8.16

1.1

1.0

225.09

211.88

mg/l

0.29

277

Behavioural syndromes associated with physiological disturbances and physical factors

201

1298

1.55

8.14

1.1

219.75

232.22

mg/l

0.49

176

1133

Use of anticholinesterases

284

2.11

8.11

1.1

256.45

331.04

mg/l

3.12

248

N06DA Anticholinesterases

284

2.11

8.11

1.1

256.45

331.04

mg/l

3.12

248

Asthma, hospital admissions 3, pneumonia

151

910

1.66

8.10

1.1

239.73

263.63

mg/l

1.10

130

801

Asthma-related pneumonia or sepsis

151

910

1.66

8.10

1.1

239.73

263.63

mg/l

1.10

130

801

Generalized anxiety disorder

106

581

1.84

8.02

1.1

202.39

239.29

mg/l

2.83

514

Other arthritis (FG)

150

907

1.66

8.00

1.1

341.44

260.39

mg/l

0.81

132

786

Other hearing loss

459

1.93

8.00

1.1

248.80

297.89

mg/l

1.92

402

Benign neoplasms

487

2067

1.34

7.96

1.1

242.49

237.66

mg/l

0.24

435

1803

Complications of surgical and medical care, not elsewhere classified

484

2617

1.33

7.95

1.1

254.21

269.65

mg/l

0.42

428

2294

Asthma-related pneumonia

150

908

1.66

7.92

1.1

239.73

263.16

mg/l

1.07

130

799

Respiratory insufficiency

3.14

7.92

1.0

1.1

588.77

311.28

mg/l

0.55

Other heart diseases

278

1260

1.46

7.92

1.1

232.52

252.44

mg/l

1.19

245

1112

Covid-19 suspected case

137

812

1.70

7.91

1.1

284.87

236.62

mg/l

0.41

128

712

Convergent concomitant strabismus

189

2.52

7.91

1.1

224.19

240.72

mg/l

0.26

162

Other medical care

154

918

1.64

7.88

1.1

285.85

267.57

mg/l

0.48

131

812

Benign neoplasms

561

2401

1.31

7.86

1.1

249.64

256.81

mg/l

0.33

501

2091

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

458

2145

1.34

7.82

1.1

296.71

262.20

mg/l

0.94

402

1893

458

2145

1.34

7.82

1.1

296.71

262.20

mg/l

0.94

402

1893

Other disorders of ear

423

2085

1.35

7.81

1.1

258.36

283.41

mg/l

1.40

380

1832

Post-traumatic stress disorder

310

2.15

7.78

1.1

198.72

221.91

mg/l

0.89

270

TMD related operations

102

559

1.84

7.73

1.1

225.91

249.95

mg/l

1.07

493

Correction of physiology of bite - demanding therapy visit

228

2.35

7.72

1.1

206.63

231.69

mg/l

0.79

202

Anterior Iridocyclitis

109

610

1.80

7.71

1.1

277.62

261.81

mg/l

0.21

532

Inflammatory diseases of female pelvic organs

342

1854

1.39

7.69

1.1

220.29

226.30

mg/l

0.24

295

1623

Spondyloarthritis

454

1.92

7.66

1.1

254.56

267.68

mg/l

0.14

398

Other disorders of adrenal gland

118

2.92

7.61

1.2

1.1

415.43

227.39

mg/l

0.72

101

Benign neoplasm of brain and other parts of central nervous system

141

2.72

7.51

1.1

302.16

272.33

mg/l

0.32

120

Benign neoplasm of brain and other parts of central nervous system

141

2.72

7.51

1.1

302.16

246.36

mg/l

0.77

121

Anti-inflammatory and antirheumatic products, non-steroids

158

479

1.66

7.49

1.1

245.49

286.87

mg/l

1.01

135

418

Tinnitus

109

616

1.78

7.47

1.1

234.13

277.35

mg/l

1.99

102

541

Acute bronchitis

187

1191

1.54

7.39

1.1

277.44

257.97

mg/l

0.18

156

1056

Nonorganic sleeping disorders

120

700

1.72

7.38

1.1

214.64

240.08

mg/l

1.34

108

615

Chronic periapical parodontitis

100

553

1.82

7.37

1.2

1.1

260.66

281.95

mg/l

0.64

484

Injuries to the knee and lower leg

626

2816

1.27

7.31

1.1

274.44

261.91

mg/l

0.53

559

2465

Disorders of adult personality and behaviour

187

1222

1.54

7.27

1.1

209.00

238.75

mg/l

2.99

162

1081

Other bacterial diseases

433

2252

1.33

7.24

1.1

339.10

266.08

mg/l

2.29

371

1988

Myopia

457

1.90

7.22

1.1

226.57

239.67

mg/l

0.29

403

Injury, poisoning and certain other consequences of external causes

329

1177

1.40

7.20

1.0

1.1

260.66

267.53

mg/l

0.16

282

1033

Scleritis and episcleritis

162

2.56

7.18

1.0

1.1

259.59

251.54

mg/l

0.05

143

Dental pulpitis 4, only avohilmo

595

2427

1.28

7.17

1.1

240.79

273.89

mg/l

2.87

518

2142

Intermittent heterotropia

199

2.39

7.12

1.1

223.68

226.83

mg/l

0.03

171

Weight loss

218

2.31

7.08

1.1

296.52

267.18

mg/l

0.29

189

Tonsillectomy and adenotomy

391

2027

1.35

7.07

1.1

223.28

237.21

mg/l

0.70

346

1788

Polymyalgia rheumatica

187

2.42

7.07

1.0

248.97

298.26

mg/l

1.42

166

Other septicaemia

134

799

1.65

7.05

1.1

314.30

280.13

mg/l

0.81

112

712

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.66

7.05

1.1

1.0

257.68

255.67

mg/l

0.01

Fitting and adjustment of other devices

107

568

1.76

7.02

1.1

355.89

293.78

mg/l

0.42

498

Diseases of male genital organs

245

843

1.47

6.96

1.1

303.65

343.99

mg/l

1.17

217

743

Other complications of surgical and medical care, not elsewhere classified

246

2.21

6.90

1.2

1.1

213.67

261.31

mg/l

1.61

214

Disorders of psychological development

482

1.82

6.89

1.1

231.10

224.89

mg/l

0.08

414

Urticaria and erythema

202

1363

1.49

6.76

1.1

249.33

237.90

mg/l

0.25

173

1199

Acute and subacute iridocyclitis

100

569

1.77

6.75

1.1

283.14

261.42

mg/l

0.28

499

Hypothyroidism, strict autoimmune, 3 medication purchases required

428

2216

1.32

6.75

1.1

246.57

249.27

mg/l

0.10

377

1942

Insomnia

562

1.77

6.74

1.1

212.79

247.13

mg/l

1.98

489

3.55

6.74

1.1

211.40

250.69

mg/l

0.80

Infections with a predominantly sexual mode of transmission

207

1407

1.48

6.67

1.1

231.57

225.51

mg/l

0.20

186

1234

Deviated nasal septum

146

920

1.59

6.66

1.1

297.33

297.25

mg/l

0.00

135

808

Disorders of lipoprotein metabolism and other lipidaemias

330

1514

1.37

6.66

1.1

303.78

300.01

mg/l

0.09

288

1338

Hyperkinetic disorders, excluding more controls

368

1.94

6.62

1.1

203.95

233.72

mg/l

1.01

322

Dental pulpitis 1, only avohilmo

591

2437

1.27

6.58

1.1

240.16

273.97

mg/l

2.98

512

2152

Presence of other functional implants

189

886

1.51

6.58

1.1

313.73

300.24

mg/l

0.25

153

781

Complications of procedures, not elsewhere classified

380

2481

1.33

6.44

1.1

255.85

271.32

mg/l

0.33

337

2180

Thyroiditis, ILD-related definition

287

2.07

6.41

1.2

1.1

211.98

231.54

mg/l

0.40

255

Disorders of speech understanding and production

133

2.62

6.41

1.1

244.69

203.75

mg/l

0.89

118

Other and unspecified effects of external causes

161

1049

1.54

6.40

1.1

222.36

244.65

mg/l

1.01

140

929

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

249

1766

1.41

6.39

1.1

270.76

265.97

mg/l

0.05

218

1556

Bipolar affective disorders

114

685

1.67

6.35

1.1

237.34

245.56

mg/l

0.22

100

605

Ménière disease

197

2.30

6.35

1.0

1.1

271.59

281.26

mg/l

0.13

167

Other acute lower respiratory infections

246

1664

1.41

6.33

1.1

277.80

260.68

mg/l

0.21

207

1481

Other and unspecified mood [affective] disorders

249

2.15

6.32

1.1

202.04

233.47

mg/l

1.01

214

Urticaria

171

1133

1.52

6.30

1.1

242.33

237.84

mg/l

0.08

145

996

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

159

1039

1.54

6.24

1.1

237.96

250.39

mg/l

0.37

132

916

Other disorders of eyelid

141

865

1.58

6.24

1.2

1.1

275.89

287.81

mg/l

0.26

122

754

Persons with potential health hazards related to communicable diseases

246

1739

1.41

6.19

1.1

248.64

233.39

mg/l

0.18

200

1538

Senile cataract

218

930

1.46

6.17

1.1

304.25

314.81

mg/l

0.20

189

825

Injuries to the thorax

184

1243

1.48

6.16

1.1

329.79

274.99

mg/l

0.63

155

1103

Inflammatory disease of uterus

541

1.75

6.15

1.0

1.1

231.07

208.17

mg/l

0.52

476

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

250

1123

1.42

6.09

1.1

241.95

249.99

mg/l

0.26

221

986

Other diseases of pleura

145

824

1.56

6.08

1.1

419.06

304.47

mg/l

0.70

125

721

Retinal vascular occlusion

182

2.32

6.07

1.1

379.83

289.93

mg/l

0.76

157

Hydrocephalus

134

2.56

6.03

1.1

1.0

334.69

254.60

mg/l

0.83

110

Other problems related to primary support group, including family circumstances

459

1.80

6.00

1.1

215.66

218.86

mg/l

0.07

405

Episcleritis

141

2.51

5.95

1.0

1.1

270.95

247.99

mg/l

0.14

123

Other arrhythmias

314

1785

1.35

5.93

1.1

241.19

267.67

mg/l

1.53

261

1580

Retinal vascular disorders

184

2.29

5.93

1.1

379.83

289.12

mg/l

0.77

159

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

224

1583

1.42

5.89

1.1

263.78

239.05

mg/l

0.69

195

1405

Other congenital malformations of circulatory system

3.44

5.89

1.2

1.1

231.30

228.37

mg/l

0.04

Other disorders of bone

110

669

1.65

5.89

1.0

1.1

210.62

253.92

mg/l

3.43

587

Specific personality disorders

149

974

1.54

5.88

1.1

207.64

239.63

mg/l

3.11

128

860

Chronic iridocyclitis

130

2.57

5.88

1.2

1.1

311.00

252.87

mg/l

0.24

111

Reimbursement for rheumatic diseases

265

1927

1.38

5.85

1.1

262.69

257.56

mg/l

0.13

233

1696

Disorders of mineral metabolism

179

2.31

5.85

1.2

1.1

265.88

267.28

mg/l

0.02

154

Asthma/COPD (KELA code 203)

495

2758

1.27

5.82

1.1

247.91

267.40

mg/l

0.53

432

2427

Substance abuse, excluding more controls

239

1496

1.40

5.81

1.1

283.64

287.52

mg/l

0.06

213

1322

Benign neoplasm of other and unspecified endocrine glands

292

2.00

5.78

1.1

258.00

254.65

mg/l

0.05

254

Other skin changes

355

1.90

5.75

1.2

1.1

282.19

286.79

mg/l

0.04

308

Personality disorders

170

1149

1.49

5.74

1.1

197.88

243.78

mg/l

7.17

148

1019

Pain associated with micturition

293

1.99

5.73

1.1

394.37

256.15

mg/l

0.49

248

Heartburn

246

2.09

5.71

1.1

213.73

266.65

mg/l

2.30

213

Persistent mood disorders

561

1.70

5.69

1.1

284.19

261.16

mg/l

0.23

500

Other nutritional deficiencies

336

2493

1.32

5.66

1.1

227.45

257.96

mg/l

2.30

291

2191

Presbyopia

163

2.35

5.66

1.1

246.57

279.69

mg/l

0.68

145

Influenza and pneumonia

544

2867

1.25

5.64

1.1

287.87

258.15

mg/l

0.97

481

2515

Chronic rhinitis, nasopharyngitis and pharyngitis

155

1033

1.51

5.60

1.1

244.91

248.46

mg/l

0.06

138

905

Allergic asthma (mode)

134

849

1.55

5.60

1.1

223.91

236.45

mg/l

0.39

121

741

Benign neoplasm of colon, rectum, anus and anal canal

205

1298

1.43

5.60

1.1

334.05

299.40

mg/l

0.67

188

1129

Other disorders of the genitourinary system

248

2.07

5.59

1.0

1.1

268.43

249.69

mg/l

0.32

217

Parkinson's disease, strict definition

215

2.15

5.58

1.2

1.1

272.70

317.92

mg/l

0.73

182

Allergic asthma (mode), excluding more controls

134

850

1.55

5.57

1.1

223.91

237.56

mg/l

0.43

121

740

Early lumbar disc prolapse, operated

325

1.92

5.52

1.1

242.39

246.60

mg/l

0.10

285

Disorders of conjunctiva

424

2784

1.28

5.49

1.1

245.81

254.82

mg/l

0.31

382

2442

Menorrhagia

204

784

1.44

5.44

1.1

225.61

232.58

mg/l

0.20

177

684

Unspecified/other endometriosis

399

1.82

5.42

1.1

191.39

203.82

mg/l

0.51

350

Deposits [accretions] on teeth

179

2.23

5.39

1.2

1.1

237.26

287.47

mg/l

0.92

154

Injuries to the abdomen, lower back, lumbar spine and pelvis

169

1148

1.47

5.38

1.1

284.72

260.40

mg/l

0.40

149

1018

Spondylopathies (FG)

444

1.77

5.36

1.1

252.07

258.70

mg/l

0.06

386

Fracture of rib(s), sternum and thoracic spine

110

686

1.61

5.36

1.1

375.24

290.54

mg/l

0.58

600

Injuries to the shoulder and upper arm

369

2392

1.30

5.35

1.1

264.86

279.40

mg/l

0.63

327

2099

Oxicams

101

342

1.68

5.32

1.1

247.97

310.62

mg/l

1.49

293

Other disorders of teeth and supporting structures

557

1.68

5.32

1.1

271.75

284.17

mg/l

0.25

490

Calculus of kidney and ureter

118

750

1.58

5.31

1.1

274.06

286.56

mg/l

0.31

112

658

Infections of the skin and subcutaneous tissue

285

2129

1.34

5.27

1.1

282.20

265.03

mg/l

0.43

249

1878

Other retinal disorders

222

1281

1.39

5.25

1.1

290.15

285.24

mg/l

0.15

192

1138

Benign neoplasm: Colon

164

1098

1.47

5.23

1.1

344.43

293.91

mg/l

0.91

151

949

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

104

645

1.62

5.21

1.1

209.16

205.42

mg/l

0.11

568

Pure hypercholesterolaemia

267

1322

1.36

5.20

1.1

317.77

301.94

mg/l

0.45

241

1166

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

146

888

1.50

5.19

1.1

273.31

222.13

mg/l

0.32

122

785

Poisoning by drugs, medicaments and biological substances

141

938

1.51

5.19

1.1

248.05

241.60

mg/l

0.17

118

831

Benign neoplasm of colon, rectum, anus and anal canal

201

1015

1.42

5.13

1.1

336.14

276.92

mg/l

1.47

184

889

Parkinson's disease

243

2.02

5.12

1.2

1.1

270.95

315.10

mg/l

0.75

206

Behavioural disorders, excluding more controls

3.21

5.05

1.1

921.31

277.06

mg/l

0.45

Problems related to lifestyle

329

1.87

5.02

1.2

1.1

225.28

257.06

mg/l

1.14

290

Diabetic neuropathy

185

2.16

4.95

1.1

286.71

315.97

mg/l

0.37

155

Oter anti-inflammatory and antirheumatic agents, non-steroids

273

1.73

4.95

1.1

268.36

331.54

mg/l

1.02

234

Paroxysmal tachycardia

107

569

1.59

4.94

1.1

232.67

256.99

mg/l

0.76

503

Disorders of skin appendages

249

1850

1.35

4.94

1.1

251.71

245.33

mg/l

0.15

216

1633

Impingement syndrome of shoulder

538

1.66

4.94

1.1

329.76

283.08

mg/l

0.43

462

Hypokalaemia

227

2.04

4.90

1.1

277.71

267.30

mg/l

0.14

191

Excessive attrition of teeth

218

849

1.40

4.90

1.1

238.35

252.52

mg/l

0.47

185

752

Superficial injury of abdomen, lower back and pelvis

472

1.70

4.88

1.0

1.1

282.87

254.93

mg/l

0.41

407

Fibroblastic disorders

442

1.72

4.87

1.1

278.77

283.79

mg/l

0.09

388

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

240

1145

1.37

4.84

1.1

187.45

196.38

mg/l

0.66

220

990

Spondylolisthesis/Spondylolysis

362

1.80

4.83

1.0

1.1

260.00

257.04

mg/l

0.05

313

Mycoses

118

768

1.54

4.83

1.1

283.62

263.27

mg/l

0.48

101

674

Abnormal blood-pressure reading, without diagnosis

101

2.60

4.81

1.2

1.1

233.81

297.92

mg/l

1.31

Parkinson's disease, including avohilmo

256

1.96

4.81

1.2

1.1

270.95

313.32

mg/l

0.72

218

Dislocation, sprain and strain of joints and ligaments of knee

324

2331

1.29

4.77

1.1

265.23

263.99

mg/l

0.03

290

2037

Diseases of the digestive system

172

1208

1.42

4.75

1.1

260.77

267.45

mg/l

0.16

151

1072

Benign neoplasm of other and unspecified endocrine glands

314

1.86

4.74

1.1

258.00

265.57

mg/l

0.13

267

Dermatographic urticaria

210

2.06

4.73

1.0

1.1

197.33

223.77

mg/l

0.65

180

Melanocytic naevi of trunk

343

1.82

4.73

1.1

269.51

241.18

mg/l

0.71

298

Ovarian cyst

219

918

1.38

4.72

1.1

208.45

225.97

mg/l

0.79

194

800

Pulmonary embolism

607

1.60

4.70

1.1

361.29

280.33

mg/l

0.73

527

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

136

918

1.49

4.70

1.1

259.67

263.03

mg/l

0.07

120

814

Supplementary factors related to causes of morbidity and mortality classified elsewhere

147

1008

1.46

4.70

1.1

234.99

257.49

mg/l

1.00

127

888

Alzheimer disease, including avohilmo

270

1.79

4.68

1.0

1.1

285.91

329.49

mg/l

0.82

237

Early onset COPD, excluding more controls

373

1.77

4.67

1.2

1.1

393.34

304.70

mg/l

0.34

337

Dental pulpitis 3, only avohilmo

451

1.61

4.66

1.1

174.91

205.38

mg/l

1.65

396

Ganglion

609

1.60

4.66

1.1

259.34

245.47

mg/l

0.25

525

Pulmonary heart disease

609

1.60

4.65

1.1

361.29

280.50

mg/l

0.73

529

Other heart diseases, wide

497

2503

1.23

4.64

1.1

233.48

268.00

mg/l

3.41

427

2208

Other and unspecified coagulation defects

140

2.31

4.62

1.0

1.1

208.85

232.60

mg/l

0.44

120

Benign neoplasm: Colon

164

876

1.44

4.62

1.1

344.43

278.53

mg/l

1.35

151

770

Other diseases of jaws

179

2.14

4.60

1.2

1.1

243.17

281.90

mg/l

0.72

151

Keratitis

163

1145

1.43

4.59

1.1

272.87

256.55

mg/l

0.42

138

1019

Alzheimer disease

230

1.87

4.58

1.0

1.1

294.34

321.76

mg/l

0.40

200

Poisoning by medicine

129

867

1.49

4.58

1.1

250.98

243.16

mg/l

0.19

107

767

Other and unspecified tonsillitis

214

1332

1.37

4.56

1.1

241.14

242.98

mg/l

0.04

189

1170

Social phobias

319

1.83

4.53

1.1

214.64

239.27

mg/l

0.78

279

Phobic anxiety disorders

498

1.65

4.51

1.1

217.07

237.34

mg/l

0.55

442

Pulmonary heart disease, diseases of pulmonary circulation

102

654

1.56

4.48

1.1

356.31

280.86

mg/l

0.70

571

Dental pulpitis 3

104

478

1.57

4.46

1.1

180.94

226.60

mg/l

1.16

418

Urolithiasis

120

800

1.50

4.43

1.1

273.11

289.51

mg/l

0.45

113

705

Glaucoma suspect

119

792

1.51

4.43

1.1

274.73

285.37

mg/l

0.22

103

691

Meniscus derangement

235

1199

1.34

4.38

1.1

279.90

286.70

mg/l

0.13

206

1045

Melanocytic naevi of trunk

352

1.77

4.38

1.1

269.51

255.68

mg/l

0.27

303

Diseases of liver

136

933

1.46

4.36

1.1

248.27

276.08

mg/l

1.31

113

828

Pneumonia, organism unspecified

420

2446

1.24

4.36

1.1

314.32

261.22

mg/l

1.56

364

2145

Unspecified fall

203

1482

1.36

4.35

1.1

254.90

261.18

mg/l

0.15

170

1311

Methotrexate

353

1.76

4.33

1.0

1.1

233.36

264.18

mg/l

0.80

313

Abnormal results of function studies

197

2.04

4.33

1.2

1.1

220.62

293.72

mg/l

1.62

172

Congenital malformations, deformations and chromosomal abnormalities

328

2473

1.27

4.32

1.1

241.65

247.12

mg/l

0.16

297

2169

Polycystic ovarian syndrome, consortium definition

382

1833

1.26

4.31

1.1

219.50

226.05

mg/l

0.31

338

1597

Cerebral aneurysm, nonruptured

184

2.08

4.30

1.0

341.61

289.33

mg/l

0.20

160

Other obstetric conditions, not elsewhere classified

240

1171

1.34

4.26

1.1

188.97

197.34

mg/l

0.60

219

1011

Other disorders of skin and subcutaneous tissue

267

1878

1.30

4.24

1.1

315.75

270.84

mg/l

0.67

226

1662

Anomalies of pupillary function

3.18

4.22

1.0

1.1

196.25

232.38

mg/l

0.88

Other coagulation defects

206

2.00

4.22

1.0

1.1

218.97

234.40

mg/l

0.27

176

Adverse effects, not elsewhere classified

106

697

1.53

4.21

1.1

217.02

239.13

mg/l

0.71

613

Drug-induced adrenocortical insufficiency

3.47

4.20

1.3

1.1

314.63

219.47

mg/l

—

Dental pulpitis 2, only avohilmo

333

1333

1.28

4.19

1.1

259.78

291.62

mg/l

1.58

280

1189

Secondary and unspecified malignant neoplasm of lymph nodes

166

2.12

4.19

1.1

344.53

288.92

mg/l

0.40

142

Conjunctivitis

387

2716

1.24

4.15

1.1

232.74

253.25

mg/l

1.12

350

2383

Venous thromboembolism

186

1322

1.37

4.13

1.1

312.80

280.98

mg/l

0.46

167

1158

Acute pharyngitis

577

1.57

4.12

1.1

236.97

246.63

mg/l

0.19

511

Hyperplasia of prostate

115

432

1.52

4.12

1.1

358.12

381.42

mg/l

0.33

378

Noninfective enteritis and colitis

221

1663

1.33

4.09

1.0

1.1

262.47

254.79

mg/l

0.16

191

1478

Aneurysms, operations, SAH

330

1.76

4.08

1.0

1.1

330.25

294.43

mg/l

0.22

290

Melanocytic naevi

137

955

1.44

4.08

1.1

255.13

243.05

mg/l

0.32

117

848

Dental pulpitis 2

325

1303

1.28

4.07

1.1

256.17

291.59

mg/l

1.88

272

1161

Excessive, frequent and irregular menstruation

232

969

1.34

4.03

1.1

206.50

221.79

mg/l

0.68

205

846

Emotional disorders starting during childhood or adolescence

215

1.96

4.03

1.0

1.1

163.65

204.09

mg/l

1.43

187

Use of rivastigmine

142

2.18

4.02

1.0

1.1

226.96

308.50

mg/l

2.55

119

Polyarthropathies

309

1615

1.28

4.01

1.1

320.73

267.41

mg/l

1.06

274

1409

Volume depletion

149

2.16

4.01

1.1

1.0

231.88

273.62

mg/l

0.50

124

Lung diseases due to external agents

238

1.90

4.00

1.1

436.77

299.25

mg/l

0.37

198

Injury of muscle and tendon at shoulder and upper arm level

125

860

1.46

3.99

1.0

1.1

302.18

315.25

mg/l

0.24

114

760

Adhesive capsulitis of shoulder

325

1.76

3.99

1.1

257.16

270.11

mg/l

0.20

281

Car occupant injured in other and unspecified transport accidents

106

706

1.51

3.99

1.1

298.72

248.47

mg/l

0.33

100

613

Disorders of vitreous body and globe

164

1155

1.39

3.98

1.1

282.50

289.11

mg/l

0.15

149

1003

Diseases of tongue

137

2.20

3.96

1.1

238.72

304.51

mg/l

1.32

113

Superficial injury of lower leg

120

821

1.47

3.95

1.1

231.63

243.97

mg/l

0.42

104

716

Other noninfective gastroenteritis and colitis

110

739

1.49

3.95

1.0

1.1

269.65

254.50

mg/l

0.19

647

Appendectomy

334

2568

1.25

3.95

1.1

235.62

254.47

mg/l

1.23

295

2257

DVT of lower extremities and pulmonary embolism

136

950

1.43

3.93

1.1

336.40

279.05

mg/l

0.70

122

837

False labour

209

979

1.35

3.91

1.1

183.51

211.42

mg/l

2.96

189

847

Fenamates

282

1.68

3.89

1.1

237.06

296.44

mg/l

1.05

241

Chronic gastritis

535

1.57

3.86

1.0

1.1

286.50

288.08

mg/l

0.01

470

Vasomotor and allergic rhinitis

200

1477

1.34

3.86

1.1

231.65

245.18

mg/l

0.46

177

1285

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

469

2723

1.21

3.84

1.1

306.22

260.30

mg/l

1.45

411

2395

Emotionally unstable personality disorder

537

1.57

3.83

1.1

216.32

231.47

mg/l

0.60

468

Schizophrenia or delusion, excluding more controls

135

943

1.42

3.82

1.0

1.1

222.89

267.68

mg/l

3.27

114

837

Suicide or other Intentional self-harm

134

943

1.43

3.82

1.1

251.21

246.73

mg/l

0.11

115

833

Disorders of vitreous body

159

1127

1.38

3.82

1.1

285.36

290.02

mg/l

0.10

145

977

Preparation and fitting of bite rail to mouth

452

1.62

3.80

1.1

226.59

261.59

mg/l

1.48

395

Other predominantly sexually transmitted diseases, not elsewhere classified

112

764

1.47

3.78

1.1

248.08

225.52

mg/l

0.58

102

667

Sequelae of injuries, of poisoning and of other consequences of external causes

112

764

1.47

3.77

1.0

1.1

308.47

267.67

mg/l

0.26

671

Diaphragmatic hernia

124

863

1.44

3.75

1.1

280.64

287.44

mg/l

0.07

112

749

Type of accident

131

922

1.42

3.74

1.1

231.79

258.31

mg/l

1.26

112

817

Other and unspecified urticaria

104

701

1.49

3.72

1.1

273.42

241.10

mg/l

0.51

615

Contact with and exposure to communicable diseases

200

1503

1.33

3.72

1.1

208.41

224.13

mg/l

0.82

162

1330

Dental caries 2

414

2670

1.22

3.71

1.1

249.21

250.85

mg/l

0.02

366

2350

Procreative management

188

1182

1.35

3.71

1.1

250.70

257.33

mg/l

0.10

172

1029

Sensorineural hearing loss

262

1426

1.29

3.70

1.1

281.99

298.81

mg/l

0.50

234

1245

Pneumonias (Asthma/COPD co-morbidities)

484

2790

1.20

3.70

1.1

304.20

262.26

mg/l

1.32

426

2448

All pneumoniae

487

2799

1.20

3.69

1.1

303.37

261.94

mg/l

1.31

429

2455

Agranulocytosis

260

1.82

3.67

1.1

474.82

264.15

mg/l

0.64

227

Emotional disorders and disorders of social functioning with onset specific to childhood

243

1.84

3.65

1.0

1.1

167.00

217.21

mg/l

1.88

209

Malignant melanoma, excluding all cancers (controls excluding all cancers)

312

1.74

3.64

1.1

503.41

275.50

mg/l

0.84

278

Sudden idiopathic hearing loss

218

1.89

3.62

1.0

251.11

300.51

mg/l

0.91

186

Sequelae of injuries of upper limb

276

1.78

3.62

1.1

240.03

285.61

mg/l

1.17

237

Injury of nerves at wrist and hand level

104

2.33

3.60

1.1

217.37

259.34

mg/l

0.79

Coagulation defects, purpura and other haemorrhagic conditions

577

1.53

3.60

1.1

251.96

257.66

mg/l

0.09

502

Inflammatory diseases of prostate (prostatitis)

269

1.79

3.60

1.0

1.1

285.85

341.65

mg/l

1.50

237

Congenital iodine-deficiency syndrome/hypothyroidism

2.97

3.58

1.4

1.1

241.33

224.31

mg/l

0.15

Behavioural disorders

2.60

3.57

1.1

921.31

222.72

mg/l

0.50

Dental caries, including avohilmo

353

1453

1.24

3.56

1.1

259.71

286.76

mg/l

1.33

303

1293

Dental caries 1

353

1453

1.24

3.55

1.1

259.71

286.76

mg/l

1.33

303

1293

Acute lymphadenitis

199

1.92

3.53

1.2

1.1

212.06

257.43

mg/l

1.18

170

Atopic dermatitis

311

2130

1.25

3.50

1.1

218.47

239.31

mg/l

1.30

270

1880

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

301

1.73

3.50

1.2

1.1

343.53

281.20

mg/l

0.69

267

Myeloid leukaemia

3.20

3.50

1.3

1.0

236.15

238.83

mg/l

0.02

Spinal instabilities

2.72

3.50

1.0

251.06

252.86

mg/l

0.01

Conductive and sensorineural hearing loss

287

1577

1.26

3.47

1.1

277.73

293.42

mg/l

0.51

257

1386

All influenza (not pneumonia)

463

1.58

3.47

1.1

253.06

272.48

mg/l

0.42

400

Aplastic and other anaemias

135

919

1.40

3.44

1.1

326.74

281.96

mg/l

0.52

102

818

Other and unspecified anaemias

121

825

1.42

3.44

1.1

326.78

288.90

mg/l

0.37

732

Asthma and allergy

451

1.58

3.42

1.1

225.93

227.42

mg/l

0.02

393

Gingivitis and periodontal diseases

426

1815

1.21

3.42

1.1

248.99

276.25

mg/l

1.81

380

1604

Asthma and allergy, excluding more controls

452

1.58

3.39

1.1

225.93

227.51

mg/l

0.02

394

Other anaemias

122

833

1.42

3.39

1.1

325.82

288.16

mg/l

0.37

738

Unspecified urinary incontinence

167

1.99

3.38

1.2

1.1

356.37

259.82

mg/l

0.53

139

Glaucoma

167

1091

1.35

3.38

1.1

309.46

290.39

mg/l

0.34

142

952

Diseases of middle ear and mastoid

320

2120

1.24

3.37

1.1

251.97

242.07

mg/l

0.34

281

1863

Conjunctivitis (acute, non atopic)

137

989

1.38

3.36

1.1

253.04

243.71

mg/l

0.23

127

869

Other cataract

136

757

1.39

3.36

1.1

323.13

302.01

mg/l

0.23

119

672

Melanocytic naevi

137

993

1.38

3.35

1.1

255.13

246.68

mg/l

0.21

117

870

Lung cancer and mesothelioma

215

1.79

3.34

1.0

1.1

366.05

324.18

mg/l

0.45

191

Endometriosis

193

868

1.33

3.33

1.1

225.59

228.74

mg/l

0.07

164

760

Use of donepezil

195

1.88

3.32

1.1

270.12

313.61

mg/l

1.20

166

Rash and other nonspecific skin eruption

225

1.83

3.32

1.1

1.0

228.32

272.39

mg/l

1.16

202

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

269

1.75

3.31

1.1

508.76

270.08

mg/l

0.71

237

Hyperlipidaemia, other/unspecified

113

751

1.43

3.28

1.1

330.14

303.15

mg/l

0.69

658

Fall on and from stairs and steps

104

721

1.45

3.27

1.1

297.44

259.42

mg/l

0.55

625

Conduct disorder

2.47

3.23

1.1

921.31

248.89

mg/l

0.47

Haemorrhage from respiratory passages

108

701

1.43

3.21

1.0

1.1

264.29

304.47

mg/l

0.97

620

Other diseases of liver

474

1.55

3.17

1.1

220.46

274.24

mg/l

2.46

416

Pruritus

273

1.73

3.17

1.1

304.54

246.93

mg/l

0.58

238

Malignant neoplasm of breast

104

1065

0.70

3.16

1.2

1.1

294.39

254.53

mg/l

0.46

933

Status post-ami

0.00

3.16

0.0

1.1

—

324.22

—

Secondary hypertension

163

1.95

3.15

1.0

1.1

279.84

279.67

mg/l

0.00

143

Mouth breathing

169

1278

1.32

3.14

1.1

286.27

283.46

mg/l

0.05

135

1138

Alzheimer’s disease, wide definition

190

1.81

3.13

1.0

1.1

310.57

311.21

mg/l

0.01

163

Dental caries 1, only avohilmo

357

1495

1.22

3.13

1.1

257.96

287.02

mg/l

1.54

308

1329

Dementia in Alzheimer disease

128

2.01

3.12

1.0

278.52

327.77

mg/l

0.78

111

Dental caries 3

377

1588

1.21

3.11

1.1

258.34

279.76

mg/l

1.02

319

1416

Dental caries 2, only avohilmo

403

2656

1.20

3.08

1.1

250.95

250.42

mg/l

0.01

356

2340

Ankylosing spondylitis

224

1.79

3.06

1.1

300.32

262.37

mg/l

0.20

190

Other female pelvic inflammatory diseases

495

1.52

3.04

1.1

219.33

221.10

mg/l

0.03

440

Other and unspecified disorders of vitreous body

125

904

1.38

3.03

1.1

285.50

285.18

mg/l

0.01

112

792

Divergent concomitant strabismus

225

1.79

3.02

1.1

232.77

266.57

mg/l

0.45

193

Disturbance of activity and attention

466

1.53

3.01

1.1

202.65

220.83

mg/l

0.55

405

Open wound of wrist and hand

203

1569

1.28

3.01

1.1

264.36

272.76

mg/l

0.24

175

1393

Dental caries 2 and operation codes

401

2668

1.20

3.01

1.1

244.44

251.29

mg/l

0.10

356

2349

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

677

1.44

2.99

1.1

248.26

243.16

mg/l

0.10

598

Glomerular diseases

465

1.53

2.99

1.1

280.19

286.31

mg/l

0.08

396

Osteoporosis with pathological fracture (FG)

2.36

2.98

1.1

298.14

270.61

mg/l

0.19

Obesity and other hyperalimentation

299

2418

1.23

2.98

1.0

1.1

231.56

254.42

mg/l

1.33

264

2121

Obesity due to excess calories

223

1766

1.27

2.96

1.0

1.1

233.65

248.85

mg/l

0.60

195

1550

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

114

2.12

2.94

1.1

231.92

260.42

mg/l

0.46

Appendicitis, broad definition

359

2733

1.20

2.93

1.1

265.18

266.95

mg/l

0.03

312

2405

Arthrosis

306

1369

1.23

2.92

1.1

253.47

278.18

mg/l

1.79

267

1197

Diseases of appendix

361

2742

1.20

2.91

1.1

265.35

266.79

mg/l

0.03

314

2413

Sequelae of external causes of morbidity and mortality

623

1.45

2.90

1.1

344.68

269.33

mg/l

0.37

543

Cardiodefibrillation

702

0.60

2.90

1.1

282.66

326.77

mg/l

1.38

619

Maltreatment syndromes

192

1.84

2.89

1.2

1.1

207.04

257.44

mg/l

1.14

160

Tongue abnormality

129

2.03

2.86

1.1

239.19

270.25

mg/l

0.45

109

Hernia of abdominal wall, postoperative

359

1.59

2.85

1.1

348.02

266.74

mg/l

0.54

323

Obesity

296

2406

1.22

2.85

1.0

1.1

231.98

254.67

mg/l

1.30

261

2110

Statin medication

363

1692

1.20

2.83

1.1

292.72

269.24

mg/l

0.95

325

1479

Other metabolic disorders

376

1.58

2.82

1.2

1.1

211.74

229.47

mg/l

0.51

327

Fracture at wrist and hand level

157

1197

1.31

2.80

1.1

305.43

273.13

mg/l

0.62

137

1070

L04AC Interleukin inhibitors

151

1.93

2.80

1.1

219.11

265.97

mg/l

0.92

127

Dental caries 1 and operation codes

391

1679

1.20

2.78

1.1

257.64

283.34

mg/l

1.40

333

1497

Bacterial intestinal infections, IBD co-morbidities

409

1.54

2.78

1.1

459.29

275.00

mg/l

0.75

349

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

716

0.65

2.77

1.1

367.26

288.31

mg/l

0.87

637

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

285

1903

1.22

2.77

1.1

218.54

235.66

mg/l

0.99

247

1670

Exclusions for E4_PCOS_CONSORTIUM

378

1985

1.20

2.77

1.1

231.07

233.49

mg/l

0.10

324

1736

Other viral diseases, not elsewhere classified

678

1.42

2.76

1.2

1.1

227.50

248.00

mg/l

0.60

596

Diseases of external ear

132

985

1.34

2.75

1.1

253.18

265.59

mg/l

0.42

119

869

Other bacterial intestinal infections

427

1.53

2.73

1.1

455.76

278.84

mg/l

0.74

365

Disorders of orbit

2.16

2.71

1.2

1.1

320.75

248.36

mg/l

0.55

Endometriosis of pelvic peritoneum

624

1.43

2.70

1.1

201.52

213.51

mg/l

0.50

543

Acute appendicitis, no complications

278

2276

1.22

2.69

1.1

230.79

256.06

mg/l

1.94

243

1999

Severe visual impairment, monocular

4.29

2.69

1.6

1.1

333.75

226.58

mg/l

—

Malignant neoplasm of breast, HER2-negative

101

1026

0.72

2.69

1.2

1.1

297.28

257.56

mg/l

0.44

898

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

101

911

0.72

2.65

1.2

1.1

291.55

244.21

mg/l

0.56

793

Nephropathy related operations

296

1.63

2.65

1.2

1.1

382.58

305.61

mg/l

1.10

249

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

101

910

0.72

2.63

1.2

1.1

291.55

244.21

mg/l

0.56

793

Dialysis, with operation codes

312

1.61

2.63

1.2

1.1

369.24

311.31

mg/l

0.77

265

Leisure time condition

545

1.45

2.63

1.1

232.09

262.61

mg/l

0.94

472

Acute appendicitis

337

2666

1.19

2.61

1.1

267.30

267.35

mg/l

0.00

295

2346

Intracerebral haemorrhage

184

1.80

2.60

1.1

401.71

296.52

mg/l

1.30

156

Dental caries 3 and operation codes

414

1801

1.18

2.58

1.1

258.38

277.81

mg/l

0.95

352

1608

Persons encountering health services for specific procedures, not carried out

207

1.75

2.57

1.2

1.1

286.54

258.04

mg/l

0.19

176

Other CVD

306

1.60

2.57

1.1

290.88

291.36

mg/l

0.01

259

Other/unspecified cytomegaloviral diseases

2.76

2.56

1.2

1.1

331.75

239.85

mg/l

0.68

Misadventures to patients during surgical and medical care

346

1.57

2.55

1.1

233.78

263.72

mg/l

0.73

299

Complications of internal orthopaedic prosthetic devices, implants and grafts

402

1.52

2.54

1.0

1.1

290.13

300.46

mg/l

0.17

350

Female infertility, cervigal, vaginal, other or unspecified origin

163

845

1.29

2.51

1.1

209.92

220.84

mg/l

0.37

145

738

Gonarthrosis [arthrosis of knee](FG)

280

1355

1.22

2.51

1.1

275.77

294.51

mg/l

0.77

248

1177

Superficial injury of thorax

396

1.52

2.50

1.1

394.04

276.53

mg/l

0.42

341

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

270

1.64

2.49

1.1

311.11

259.48

mg/l

0.21

228

Assault

536

1.44

2.47

1.1

238.89

255.06

mg/l

0.36

474

Lagophthalmos

3.86

2.47

1.4

1.0

264.25

232.48

mg/l

—

Dental caries 3, only avohilmo

377

1629

1.18

2.47

1.1

254.56

280.67

mg/l

1.41

319

1452

Other disorders of glucose regulation and pancreatic internal secretion

225

1.70

2.46

1.1

253.97

278.20

mg/l

0.38

188

Melanocytic naevi, other sites/unspecified

210

1.72

2.46

1.1

220.62

244.56

mg/l

0.48

184

Other diseases of arteries and capillaries

195

1.75

2.46

1.1

1.0

361.76

279.39

mg/l

0.32

167

Rheumatoid arthritis

114

771

1.35

2.44

1.1

287.36

268.86

mg/l

0.26

101

672

Hyperkinetic disorders

498

1.45

2.44

1.1

203.95

219.61

mg/l

0.46

433

Hypoglycaemia, other or unspecified

181

1.78

2.43

1.0

1.1

243.24

274.88

mg/l

0.57

153

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

439

2566

1.16

2.43

1.1

275.87

262.67

mg/l

0.53

384

2252

Flat foot [pes planus] (acquired)

211

1.71

2.42

1.1

245.74

253.18

mg/l

0.14

190

Female infertility, associated with anovulation

384

1.52

2.40

1.1

194.75

202.44

mg/l

0.16

338

Glomerulonephritis

250

1.65

2.39

1.1

279.35

293.63

mg/l

0.14

213

Torticollis

2.78

2.38

1.2

1.1

280.00

231.86

mg/l

0.21

Renal tubulo-interstitial diseases

366

2387

1.18

2.37

1.1

312.01

255.69

mg/l

1.33

317

2089

Coeliac disease

377

1.52

2.37

1.2

1.1

261.10

252.59

mg/l

0.10

328

Drug-induced neutropenia

161

1.81

2.35

1.1

631.65

266.48

mg/l

0.66

139

Postprocedural endocrine and metabolic disorders, not elsewhere classified

346

1.54

2.34

1.2

1.1

215.89

225.61

mg/l

0.22

302

Ingrowing nail

154

1.83

2.34

1.1

317.68

260.43

mg/l

0.48

129

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

221

1.68

2.34

1.1

280.34

274.69

mg/l

0.07

192

Other disorders of conjunctiva

283

1.59

2.33

1.1

356.25

274.17

mg/l

0.60

241

Monoamine oxidase A inhibitors

268

1.61

2.31

1.0

1.1

224.68

285.51

mg/l

2.60

234

Unspecified haematuria

120

777

1.32

2.31

1.1

355.57

296.42

mg/l

0.48

114

681

Acute tubulo-interstitial nephritis

245

1791

1.21

2.31

1.1

320.11

255.46

mg/l

0.96

216

1564

Diabetic retinopathy, excluding more controls

339

1.42

2.29

1.1

316.93

323.91

mg/l

0.09

292

Other keratitis

356

1.52

2.29

1.1

265.73

265.26

mg/l

0.00

311

Haemorrhoids and perianal venous thrombosis

662

1.38

2.28

1.1

323.77

287.86

mg/l

0.37

574

Disorders of breast

217

1641

1.23

2.28

1.1

247.14

234.30

mg/l

0.23

190

1436

Iron deficiency anaemia

140

1077

1.29

2.26

1.1

275.67

258.95

mg/l

0.28

119

950

Nontraumatic intracranial haemmorrhage

333

1.53

2.25

1.1

370.72

307.97

mg/l

0.97

288

Melanocytic naevi, other sites/unspecified

216

1.67

2.25

1.1

220.62

252.81

mg/l

0.69

188

Deep endometriosis

310

1.56

2.24

1.1

212.42

211.84

mg/l

0.01

267

Superficial injury of head

674

1.37

2.23

1.1

279.37

259.74

mg/l

0.38

599

Degeneration of macula and posterior pole

105

645

1.34

2.23

1.1

309.37

307.70

mg/l

0.03

564

Other bursopathies

240

1.63

2.21

1.0

1.1

269.73

268.49

mg/l

0.01

203

Heart failure and bmi 25plus

470

0.64

2.21

1.0

1.1

303.75

329.54

mg/l

0.38

411

Malignant melanoma

295

1.56

2.21

1.1

361.65

289.70

mg/l

0.75

255

Assault by bodily force

288

1.57

2.19

1.2

1.1

255.75

265.81

mg/l

0.12

251

Chondropathies

508

1.42

2.19

1.0

1.1

204.48

260.06

mg/l

3.70

442

Other diseases of blood and blood-forming organs

143

1.83

2.19

1.1

269.15

291.45

mg/l

0.25

122

Budesonide

393

1.48

2.17

1.1

231.40

262.51

mg/l

0.90

349

Other and unspecified iron deficiency

111

842

1.32

2.15

1.1

278.32

251.07

mg/l

0.42

742

Secondary uncertain malignant neoplasm

243

1.61

2.12

1.1

331.56

288.45

mg/l

0.34

202

Malignant melanoma of skin

220

1.64

2.11

1.1

1.0

341.82

300.74

mg/l

0.31

188

Symptoms and signs involving emotional state

2.22

2.11

1.1

281.53

210.51

mg/l

0.72

Myocardial infarction, strict

792

0.73

2.11

1.1

359.68

334.96

mg/l

0.31

704

Other disorders of skin and subcutaneous tissue, not elsewhere classified

339

1.51

2.10

1.1

262.54

272.53

mg/l

0.14

289

Sequelae with surgical and medical care as external cause

462

1.43

2.10

1.1

369.04

278.18

mg/l

0.35

398

Nail disorders

236

1.62

2.10

1.1

276.97

270.07

mg/l

0.06

198

Ovarian dysfunction

340

1.51

2.09

1.0

1.1

195.63

194.87

mg/l

0.02

296

Colour vision deficiencies

5.11

2.08

1.0

1.1

184.80

240.50

mg/l

—

Collagenous colitis

229

1.62

2.08

1.0

1.1

289.13

264.24

mg/l

0.12

198

Superficial injury of wrist and hand

744

1.33

2.07

1.1

305.22

240.83

mg/l

0.40

656

Fall on same level involving ice and snow

228

1893

1.21

2.07

1.1

275.62

258.98

mg/l

0.38

199

1680

Heart failure and coronary heart disease

371

0.60

2.06

1.1

323.33

332.55

mg/l

0.09

320

Other arthrosis

183

1059

1.24

2.05

1.0

1.1

267.59

292.43

mg/l

1.05

158

922

Adenomyosis (Endometriosis of uterus)

374

1.48

2.05

1.1

220.77

226.79

mg/l

0.15

329

Recurrent dislocation and subluxation of joint

230

1.62

2.05

1.2

1.1

328.97

263.68

mg/l

0.24

195

Dental operations

270

1160

1.20

2.03

1.1

256.08

290.26

mg/l

1.63

233

1031

Striking against or struck by other objects

154

1231

1.25

2.01

1.1

327.75

264.08

mg/l

0.61

130

1096

Other disorders of male genital organs

2.01

2.00

1.2

1.1

283.72

349.02

mg/l

1.27

Autoimmune hyperthyroidism

111

1.90

2.00

1.1

237.81

242.30

mg/l

0.04

100

Other inflammation of eyelid

319

1.51

2.00

1.1

247.32

257.93

mg/l

0.22

270

Lateral epicondylitis

319

1.51

2.00

1.1

344.95

270.82

mg/l

0.39

273

Crohn's disease of small intestine

232

1.60

1.99

1.0

1.1

235.81

275.30

mg/l

0.68

199

Other disorders of patella

595

1.36

1.98

1.0

1.1

222.31

245.39

mg/l

1.08

515

Abnormal findings on antenatal screening of mother

428

1.43

1.95

1.1

192.17

195.22

mg/l

0.06

369

Preterm labour and delivery

123

961

1.28

1.95

1.1

258.07

224.57

mg/l

0.37

108

838

Dermatitis due to substances taken internally

134

1.80

1.95

1.0

268.71

241.46

mg/l

0.21

116

Childhood asthma (age<16), excluding more controls

478

1.36

1.94

1.2

1.1

235.87

218.66

mg/l

0.24

412

Other and unspecified acne

2.48

1.94

1.7

1.1

161.33

256.03

mg/l

1.49

Open wound of head

191

1547

1.22

1.93

1.1

308.88

284.49

mg/l

0.36

166

1379

Cellulitis

632

1.35

1.93

1.1

325.99

265.75

mg/l

1.02

550

Erosion of teeth

2.59

1.93

1.1

1.0

320.00

237.48

mg/l

—

Abnormal serum enzyme levels

608

1.35

1.90

1.0

1.1

266.18

340.98

mg/l

2.72

531

Other disorders of breast

389

1.44

1.89

1.1

203.96

220.20

mg/l

0.54

341

Childhood asthma (age<16)

481

1.36

1.88

1.2

1.1

235.87

218.01

mg/l

0.25

415

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

264

2206

1.18

1.87

1.1

221.53

244.18

mg/l

1.00

238

1928

Otitis externa

696

1.32

1.87

1.1

238.98

254.74

mg/l

0.50

610

Colonic or urogenital fistula

104

801

1.30

1.86

1.1

283.07

266.80

mg/l

0.38

698

Hallux rigidus

268

1.53

1.86

1.0

1.1

323.36

280.08

mg/l

0.46

232

Viral warts

317

1.49

1.85

1.0

1.1

240.76

257.93

mg/l

0.27

275

Female genital prolapse

123

554

1.28

1.84

1.1

228.95

254.66

mg/l

0.70

104

481

Other diseases of oesophagus

182

1.65

1.84

1.0

1.1

241.80

303.74

mg/l

1.92

154

All-cause Heart Failure

870

0.76

1.84

1.1

262.26

320.14

mg/l

2.44

765

Anomalies of dental arch relationship, including avohilmo

101

696

1.31

1.84

1.0

1.1

204.01

240.61

mg/l

1.91

611

Other disorders of carbohydrate metabolism

4.26

1.83

1.0

1.2

226.80

193.50

mg/l

—

FESS (DNB20)

367

1.45

1.83

1.1

254.61

274.98

mg/l

0.35

317

Bacterial pneumonia (organism specified)

148

1086

1.24

1.82

1.1

335.20

272.50

mg/l

0.60

133

969

Polyarthrosis

360

1.44

1.81

1.1

230.29

280.37

mg/l

2.23

313

Heart failure, strict

883

0.77

1.81

1.1

262.91

319.55

mg/l

2.46

777

Fissure and fistula of anal and rectal regions

735

1.31

1.80

1.1

285.37

273.68

mg/l

0.24

639

Bleeding

296

1848

1.17

1.80

1.1

314.85

279.54

mg/l

0.62

263

1630

Acute peritonitis

123

1.80

1.1

762.63

278.28

mg/l

0.60

111

Atopic dermatitis, strict definition with reimbursement

167

1326

1.22

1.79

1.1

210.56

227.33

mg/l

0.71

148

1172

Endometriosis ASRM stages 1,2

685

1.32

1.77

1.1

201.52

213.05

mg/l

0.52

613

Endometriosis diagnosis and infertility diagnosis occurring together

437

1.40

1.77

1.1

201.59

206.86

mg/l

0.17

386

Other and unspecified nonorganic psychotic disorders

103

799

1.29

1.77

1.0

1.1

221.81

260.18

mg/l

1.40

710

Infectious mononucleosis

387

1.43

1.76

1.1

261.33

231.70

mg/l

0.24

330

DVT of lower extremities

395

1.42

1.76

1.1

267.46

276.59

mg/l

0.12

342

Benign neoplasm: Long bones of lower limb

1.94

1.75

1.0

1.1

225.82

244.57

mg/l

0.29

Nutritional anaemias

156

1237

1.23

1.75

1.1

278.94

263.59

mg/l

0.27

131

1086

Other inflammatory liver diseases

162

1.67

1.74

1.1

257.63

267.21

mg/l

0.11

140

Malignant neoplasm of digestive organs

676

0.70

1.73

1.1

399.05

308.44

mg/l

0.77

596

Other disorders of the musculoskeletal system and connective tissue

347

1.44

1.72

1.2

1.1

275.82

275.66

mg/l

0.00

297

Coronary revascularization (ANGIO or CABG)

707

0.75

1.72

1.1

309.53

342.48

mg/l

0.63

627

Gonarthrosis

235

1137

1.19

1.72

1.1

264.14

289.66

mg/l

1.18

208

985

Diabetic retinopathy

447

1.32

1.72

1.1

313.03

319.12

mg/l

0.09

386

Female infertility

173

877

1.22

1.72

1.1

215.53

219.72

mg/l

0.11

155

762

Ethmoidectomy

381

1.42

1.71

1.1

252.47

273.60

mg/l

0.38

331

Other misadventures during surgical and medical care

2.31

1.71

1.1

192.64

251.09

mg/l

1.63

Bacterial, viral and other infectious agents

291

1.48

1.69

1.1

255.25

274.64

mg/l

0.33

252

Thrombocytopenia, unspecified

156

1.67

1.69

1.1

358.60

276.45

mg/l

0.61

136

Medicines for HER+ breast cancer

902

0.74

1.69

1.2

1.1

318.82

253.72

mg/l

0.54

787

Other pleural conditions

164

1.65

1.67

1.0

1.1

230.86

298.62

mg/l

1.32

137

Other congenital malformations

308

1.47

1.67

1.1

181.08

225.08

mg/l

2.10

264

Medical abortion

307

1442

1.16

1.67

1.1

215.75

223.35

mg/l

0.41

271

1256

Maternal care for other conditions predominantly related to pregnancy

125

989

1.25

1.66

1.1

196.23

203.11

mg/l

0.34

102

855

Crohn disease (strict definition, all UC cases excluded)

157

1.66

1.0

1.1

214.86

264.09

mg/l

0.74

131

Benign neoplasm: Long bones of lower limb

1.90

1.65

1.0

1.1

225.82

258.04

mg/l

0.56

Superficial injury of hip and thigh

317

1.45

1.65

1.1

218.38

279.58

mg/l

2.40

263

Unspecified mental disorder

191

1600

1.20

1.65

1.0

1.1

229.31

256.18

mg/l

1.50

162

1414

Rheumatoid arthritis, including avohilmo

130

1048

1.24

1.64

1.1

275.74

263.74

mg/l

0.18

115

919

Inflammatory bowel disease

143

1165

1.23

1.64

1.1

238.47

254.51

mg/l

0.59

121

1031

Other diseases of the digestive system

677

1.30

1.63

1.1

273.83

292.28

mg/l

0.34

596

Use of memantine

205

1.53

1.62

1.1

288.11

317.01

mg/l

0.47

178

Use of other anti-dementia drugs

205

1.53

1.62

1.1

288.11

317.01

mg/l

0.47

178

Viral and other specified intestinal infections

113

877

1.26

1.62

1.1

212.42

239.23

mg/l

1.25

101

767

Alcohol use disorder, Swedish definition

215

1692

1.18

1.61

1.1

280.75

285.35

mg/l

0.08

187

1485

conjunctival degenerations and deposits

2.34

1.60

1.0

1.1

216.20

228.92

mg/l

—

Allergic conjunctivitis

274

2333

1.16

1.60

1.1

221.50

245.74

mg/l

1.16

246

2042

Mental and behavioural disorders due to opioids

128

1.73

1.60

1.0

1.1

222.71

251.42

mg/l

0.57

105

Emergency coronary revascularization (for ACS)

768

0.77

1.60

1.1

306.11

336.43

mg/l

0.63

680

Atopic dermatitis, strict definition

164

1332

1.21

1.60

1.1

210.71

225.35

mg/l

0.58

145

1176

Localized swelling, mass and lump of skin and subcutaneous tissue

101

794

1.27

1.59

1.2

1.1

361.61

267.21

mg/l

0.85

695

Mental and behavioural disorders due to psychoactive substance use

248

2010

1.17

1.59

1.1

282.72

280.92

mg/l

0.03

219

1774

Mental disorders, not otherwise specified

312

1.45

1.59

1.0

1.1

204.26

234.48

mg/l

0.99

270

Gastroduodenal ulcer

454

1.36

1.58

1.1

287.63

316.21

mg/l

0.50

403

Perineal laceration during delivery

785

0.75

1.57

1.0

1.1

223.49

191.49

mg/l

0.62

681

GI-bleeding

672

1.30

1.57

1.1

275.58

292.98

mg/l

0.31

589

Glucosamine medication

122

782

1.25

1.56

1.1

299.18

305.67

mg/l

0.08

108

691

Fracture of lower leg, including ankle

213

1804

1.18

1.56

1.1

299.38

274.64

mg/l

0.56

192

1590

Amenorrhoea

305

1.45

1.56

1.1

224.32

199.07

mg/l

0.42

270

Candidiasis

397

1.39

1.56

1.1

285.00

250.82

mg/l

0.56

345

Nonsuppurative otitis media

127

889

1.24

1.54

1.1

245.50

243.15

mg/l

0.03

114

777

Early lumbar disc prolapse operation

458

1.36

1.53

1.1

242.39

254.11

mg/l

0.34

400

Dermatophytosis

306

1.44

1.53

1.1

281.28

301.68

mg/l

0.30

260

Amputation of foot

0.00

1.51

0.0

1.1

—

282.00

—

Type 2 diabetes, wide definition

289

1638

1.15

1.51

1.1

315.16

283.20

mg/l

1.01

245

1448

KRA_PSY_EATING, excluding more controls

306

1.44

1.51

1.1

203.11

202.24

mg/l

0.01

267

Rosacea

307

1.44

1.51

1.1

224.92

250.59

mg/l

0.73

270

Vasomotor rhinitis (mode)

193

1.56

1.51

1.1

225.50

278.01

mg/l

0.90

168

Acute generalized exanthematous pustulosis

108

1.77

1.51

1.0

1.1

290.93

245.61

mg/l

0.31

Biological medication for rheuma

572

1.31

1.50

1.1

219.63

254.18

mg/l

1.13

508

Papulosquamous disorders

143

1178

1.22

1.50

1.1

260.42

268.46

mg/l

0.15

122

1035

Substance abuse

239

1969

1.16

1.49

1.1

283.64

282.61

mg/l

0.02

213

1735

Recurrent dislocation of patella

210

1.53

1.48

1.1

205.63

221.31

mg/l

0.43

179

Vulvovaginal ulceration/inflammation in other diseases

210

1.53

1.48

1.1

267.78

203.82

mg/l

0.84

181

Other disorders of veins

138

1135

1.22

1.47

1.1

331.20

261.51

mg/l

0.67

123

994

Suppurative and unspecified otitis media

202

1525

1.18

1.46

1.1

232.15

238.91

mg/l

0.18

181

1337

Obesity, other/unspecified

153

1274

1.20

1.45

1.1

228.01

242.69

mg/l

0.69

139

1116

Schizophrenia

569

0.70

1.45

1.1

245.15

267.43

mg/l

0.50

500

Gout

398

1.35

1.44

1.0

1.1

456.09

339.80

mg/l

0.95

346

Disorder of lipoprotein metabolism, unspecified

228

1.49

1.43

1.1

307.74

308.56

mg/l

0.01

195

Infections of genitourinary tract in pregnancy

370

1.38

1.43

1.1

192.87

215.41

mg/l

1.12

320

Other (seronegative) rheumatoid arthritis, wide

447

1.34

1.42

1.0

1.1

261.88

266.39

mg/l

0.07

389

Extracorporeal dialysis

133

1.66

1.42

1.1

1.0

435.35

291.21

mg/l

1.49

119

Bacterial pneumonia, not elsewhere classified

128

928

1.22

1.42

1.2

1.1

350.20

275.11

mg/l

0.64

116

827

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

392

2276

1.12

1.42

1.1

286.09

274.47

mg/l

0.21

349

1998

Diseases of peritoneum

221

1.50

1.40

1.1

1.0

528.00

282.09

mg/l

0.46

191

Dental caries 2 and operation codes, only avohilmo

347

1907

1.13

1.40

1.1

253.42

253.47

mg/l

0.00

312

1658

Excessive vomiting in pregnancy

346

1.39

1.40

1.1

187.25

212.28

mg/l

0.94

296

Left ventricular outflow tract obstruction, narrow definition

138

0.43

1.40

1.0

1.1

274.33

298.50

mg/l

—

118

Purpura and other haemorrhagic conditions

355

1.38

1.39

1.1

267.45

278.09

mg/l

0.11

301

Iron deficiency

1.96

1.39

1.0

1.1

200.17

237.03

mg/l

—

Other gastritis (incl. Duodenitis)

510

1.32

1.38

1.1

272.84

295.31

mg/l

0.43

447

Other complications of labour and delivery, not elsewhere classified

609

0.73

1.38

1.1

175.55

190.72

mg/l

0.63

528

Disorders of parathyroid gland

385

1.36

1.37

1.1

292.70

272.13

mg/l

0.14

336

Allergic contact dermatitis

416

1.35

1.37

1.0

1.1

270.76

239.09

mg/l

0.34

363

Heart failure,strict

840

0.80

1.36

1.1

264.89

318.20

mg/l

2.19

741

Crohn disease

451

1.33

1.36

1.0

1.1

226.66

256.44

mg/l

0.75

396

Fracture of lumbar spine and pelvis

442

1.34

1.35

1.1

240.96

278.07

mg/l

1.00

375

Retinal breaks without detachment

340

1.39

1.35

1.1

267.54

285.25

mg/l

0.22

300

Chronic kidney disease

527

1.30

1.35

1.0

1.1

335.91

311.50

mg/l

0.34

458

Mental and behavioural disorders due to alcohol, excluding acute intoxication

169

1430

1.18

1.35

1.1

282.91

290.29

mg/l

0.11

149

1268

227

1806

1.15

1.35

1.1

278.35

281.91

mg/l

0.06

196

1590

Bacterial pneumoniae

136

999

1.21

1.34

1.2

1.1

341.15

272.17

mg/l

0.62

123

889

Allergic rhinitis

161

1346

1.19

1.34

1.1

230.31

234.33

mg/l

0.11

142

1186

Injury of muscle and tendon at wrist and hand level

392

1.36

1.33

1.2

1.1

340.51

274.24

mg/l

0.53

348

Phlebitis and thrombophlebitis (not including DVT)

566

1.29

1.33

1.1

253.82

265.73

mg/l

0.24

492

Artrosis, including avohilmo

380

1863

1.12

1.32

1.1

244.34

284.82

mg/l

4.25

337

1631

Alcohol use disorder, ICD-based

155

1307

1.19

1.31

1.1

282.29

289.54

mg/l

0.10

136

1161

Care involving dialysis

160

1.57

1.31

1.1

418.33

303.54

mg/l

1.09

132

Complications predominantly related to the puerperium

130

1079

1.21

1.31

1.0

1.1

194.63

211.49

mg/l

1.27

113

951

242

1891

1.15

1.31

1.1

274.56

279.82

mg/l

0.11

210

1663

Fracture of foot, except ankle

106

862

1.23

1.31

1.1

251.72

245.19

mg/l

0.10

765

Abnormal findings in secretions and smears from cervix uteri vagina vulva

244

1673

1.15

1.30

1.1

201.72

221.53

mg/l

1.67

215

1470

Seropositive rheumatoid arthritis

594

1.28

1.29

1.1

306.36

269.67

mg/l

0.39

516

Diseases of salivary glands

534

1.29

1.28

1.2

1.1

204.25

262.48

mg/l

3.78

468

Myocardial infarction

861

0.81

1.28

1.1

343.01

330.40

mg/l

0.17

767

Other deformities of toe(s)

1.94

1.28

1.0

1.1

309.92

267.21

mg/l

0.20

Sequelae of other external causes

122

1.65

1.27

1.1

286.07

256.59

mg/l

0.15

103

COPD (mode)

431

1.29

1.25

1.2

1.1

402.26

316.22

mg/l

0.36

384

Failure and rejection of transplanted organs and tissues

2.24

1.25

1.3

1.1

375.00

251.42

mg/l

—

Other respiratory diseases principally affecting the interstitium

303

1.39

1.24

1.1

259.36

293.82

mg/l

0.75

260

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.02

1.24

1.0

197.11

189.97

mg/l

—

Early onset COPD

511

1.29

1.24

1.2

1.1

393.34

298.82

mg/l

0.37

443

Substance use, excluding alcohol

707

1.25

1.23

1.1

282.33

257.42

mg/l

0.30

635

Toxic effects of substances chiefly nonmedicinal as to source

364

1.35

1.22

1.1

198.02

263.99

mg/l

3.77

316

Polycystic ovarian syndrome, broad definition

557

1.28

1.21

1.0

1.1

199.28

198.37

mg/l

0.02

491

Viral pneumonia

339

1.36

1.21

1.1

286.37

274.57

mg/l

0.15

290

Acute laryngitis and tracheitis

505

1.29

1.21

1.1

198.04

239.96

mg/l

1.84

443

Other and unspecified psoriasis

148

1.56

1.20

1.0

1.1

313.81

293.21

mg/l

0.08

125

Alcohol abuse, main dg, excluding more controls

400

1.33

1.20

1.2

1.1

228.63

283.01

mg/l

2.66

355

Primary open-angle glaucoma, strict

399

1.33

1.20

1.1

319.49

292.90

mg/l

0.32

350

Other hammer toe(s) (acquired)

302

1.37

1.19

1.0

1.1

314.57

288.26

mg/l

0.28

264

Gastric ulcer

314

1.37

1.19

1.1

298.35

311.50

mg/l

0.14

271

Renal failure

106

796

1.22

1.19

1.1

307.51

305.42

mg/l

0.03

694

Chronic pancreatitis

272

1.40

1.19

1.1

339.56

321.33

mg/l

0.09

231

L02BG Aromatase inhibitors

683

0.76

1.18

1.2

1.1

334.21

261.39

mg/l

0.44

603

Ankylosing spondylitis, ICD10

281

1.39

1.18

1.1

300.32

281.16

mg/l

0.09

238

Rare circulating lymphoid malignancy

1.88

1.18

1.1

1.0

270.33

238.66

mg/l

0.20

Atrial fibrillation and flutter with reimbursement

390

1.27

1.17

1.1

391.98

295.60

mg/l

0.41

345

Other disorders of kidney and ureter

273

1.39

1.17

1.1

539.90

296.24

mg/l

0.58

232

Deep bite

336

1.33

1.16

1.1

194.64

246.72

mg/l

1.67

290

Intestinal stricture

677

1.24

1.15

1.1

271.80

289.74

mg/l

0.38

594

Contact with sharp glass

118

1.62

1.15

1.1

198.43

253.04

mg/l

0.99

Diabetic retinopathy, strict definition

338

1.33

1.14

1.0

1.1

290.02

296.48

mg/l

0.07

293

Sulfasalazine

106

878

1.21

1.13

1.0

1.1

293.39

260.37

mg/l

0.51

779

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

127

1070

1.19

1.13

1.1

239.61

245.28

mg/l

0.09

112

947

Primary gonarthrosis, bilateral

130

959

1.19

1.12

1.0

1.1

277.25

313.83

mg/l

1.13

114

842

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.35

1.12

1.1

1193.00

246.00

mg/l

—

Endometriosis ASRM stages 3,4

806

1.22

1.12

1.1

234.77

218.10

mg/l

0.34

717

Other abnormal products of conception

183

1055

1.16

1.12

1.1

187.96

204.28

mg/l

1.53

161

922

Diabetes, insulin treatment (Kela reimbursement)

356

2410

0.90

1.11

1.1

312.58

275.05

mg/l

1.44

314

2113

Other puerperal infections

371

1.33

1.11

1.0

1.1

191.38

199.29

mg/l

0.28

325

Mental and behavioural disorders due to alcohol

200

1702

1.14

1.11

1.1

275.35

285.12

mg/l

0.18

176

1498

Use of disulfiram, acamprosate or naltrexone

268

1.38

1.10

1.1

258.58

303.43

mg/l

0.96

230

Corneal ulcer

592

1.25

1.10

1.1

256.10

262.08

mg/l

0.10

520

Acute renal failure

380

1.32

1.10

1.1

311.88

313.18

mg/l

0.01

324

Invasive ventilation

168

1.49

1.09

1.0

1.1

301.56

297.11

mg/l

0.03

141

L04AD Calcineurin inhibitors

320

1.35

1.09

1.1

317.80

283.50

mg/l

0.39

274

Dental operations, only avohilmo

281

1281

1.12

1.09

1.1

265.09

286.35

mg/l

0.81

244

1139

Cholecystectomy

254

1996

1.13

1.08

1.1

275.31

267.14

mg/l

0.21

226

1742

Malignant neoplasm of cervix uteri

2.20

1.08

1.0

203.86

190.26

mg/l

—

Follicular cysts of skin and subcutaneous tissue

540

1.26

1.08

1.1

251.32

267.56

mg/l

0.32

468

Familial hypercholesterolemia

252

1.39

1.08

1.1

345.57

306.99

mg/l

0.47

220

Ischemic heart diseases

256

1423

1.13

1.07

1.1

280.18

305.25

mg/l

0.92

215

1250

Antenatal screening

100

679

0.83

1.06

1.0

1.1

238.29

209.11

mg/l

0.32

572

Acute suppurative otitis media

150

1205

1.16

1.05

1.1

232.70

239.28

mg/l

0.14

133

1065

Ulcerative colitis

104

868

1.20

1.05

1.1

244.32

257.56

mg/l

0.39

771

Hereditary retinal dystrophy

2.07

1.03

1.0

1.1

227.71

209.34

mg/l

—

Noninflammatory disorders of female genital tract

227

1008

1.13

1.02

1.1

205.03

219.13

mg/l

0.60

197

880

Procedures for purposes other than remedying health state

1.90

1.01

1.0

1.1

256.40

239.59

mg/l

—

Other, unspecified and serous retinal detachments

1.90

1.01

1.2

1.1

241.60

264.07

mg/l

—

Congenital malformations of aortic and mitral valves

109

0.46

1.00

1.0

1.1

314.00

274.43

mg/l

—

Crohn's disease NAS

222

1.40

1.00

1.0

1.1

223.38

261.41

mg/l

0.82

190

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

330

1.30

1.00

1.0

1.1

405.11

294.74

mg/l

1.59

295

Abnormal findings in nipple discharge synovial fluid wound secretions

2.01

1.00

1.1

1.0

189.00

238.80

mg/l

—

Dysplasia of cervi uteri

123

809

1.18

0.99

1.0

1.1

196.73

220.18

mg/l

1.17

104

707

Injuries to the hip and thigh

139

1094

1.16

0.99

1.1

263.56

273.33

mg/l

0.17

120

971

Atherosclerosis, excluding cerebral and coronary sclerosis

557

0.79

0.98

1.0

1.1

317.33

323.14

mg/l

0.06

492

Open bite that required surgery (Lefort1 or BSSRO)

1.96

0.97

1.0

1.1

206.43

218.84

mg/l

—

Unspecified acute lower respiratory infection

450

1.27

0.97

1.2

1.1

270.33

273.54

mg/l

0.04

390

Oligomenorrhoea

132

1.52

0.97

1.2

1.0

233.35

211.35

mg/l

0.55

114

Injury of eye and orbit

486

1.26

0.97

1.0

1.1

257.89

270.10

mg/l

0.24

428

Other diseases of anus and rectum

729

1.21

0.96

1.1

278.30

280.34

mg/l

0.03

629

Peripheral artery disease

631

0.80

0.96

1.1

445.34

321.34

mg/l

0.48

556

Adalimumab

310

1.33

0.96

1.1

231.87

261.32

mg/l

0.46

269

Erosion of teeth, including avohilmo

723

1.20

0.96

1.1

268.42

242.50

mg/l

0.32

642

Malignant neoplasm of breast, HER-positive

814

0.81

0.95

1.2

1.1

323.65

257.27

mg/l

0.53

708

Other condition

416

1.28

0.95

1.1

230.10

260.50

mg/l

1.00

360

Single delivery by caesarean section

575

0.82

0.95

1.2

1.1

196.17

205.59

mg/l

0.27

499

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

109

810

1.18

0.95

1.1

339.57

283.27

mg/l

1.16

717

Ulcerative rectosigmoiditis

259

1.35

0.95

1.0

1.1

242.07

281.98

mg/l

1.14

223

Benign neoplasm: Anus and anal canal

1.77

0.94

1.2

1.0

281.22

237.76

mg/l

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

116

0.52

0.94

1.0

1.1

265.83

253.81

mg/l

—

105

Diseases of arteries, arterioles and capillaries (FINNGEN)

402

1.24

0.93

1.1

292.59

293.28

mg/l

0.01

355

Prolonged pregnancy

731

0.81

0.93

1.1

186.71

206.37

mg/l

0.71

639

Ulcer of oesophagus

117

1.54

0.93

1.1

1.0

248.17

308.33

mg/l

1.13

104

Pregnancy with abortive outcome

309

1463

1.11

0.92

1.1

219.51

222.71

mg/l

0.12

272

1272

Acne

472

1.25

0.91

1.2

1.1

280.35

216.06

mg/l

0.59

401

Paralytic ileus and intestinal obstruction

562

1.23

0.91

1.1

262.38

298.32

mg/l

1.07

483

Superficial injury of forearm

322

1.31

0.91

1.1

255.51

250.16

mg/l

0.06

275

Acne vulgaris

375

1.28

0.91

1.1

292.10

221.08

mg/l

0.51

320

Open wound of ankle and foot

296

1.32

0.90

1.1

198.23

255.13

mg/l

2.64

251

Vascular dementia

1.71

0.90

1.1

1.0

215.33

284.33

mg/l

1.53

Pregnancy, childbirth and the puerperium

603

0.84

0.90

1.1

192.88

214.69

mg/l

1.07

518

Other and unspecified intracranial injuries

1.75

0.90

1.0

226.27

234.32

mg/l

0.08

Gestational [pregnancy-induced] hypertension

134

1160

1.15

0.89

1.1

194.66

208.08

mg/l

0.66

124

1011

Generalized epilepsy, strict definition

1.70

0.89

1.0

1.1

181.50

235.37

mg/l

0.71

Other specific arthropathies, wide

1.91

0.88

1.0

1.1

199.13

228.03

mg/l

—

Burns and corrosions

448

1.25

0.88

1.1

226.67

263.33

mg/l

1.36

389

Injury of muscle and tendon at hip and thigh level

254

1.34

0.88

1.1

290.07

292.01

mg/l

0.02

219

Other surgical follow-up care

1.65

0.88

1.1

235.23

212.59

mg/l

0.34

Gonarthrosis,primary

285

1624

1.10

0.88

1.1

279.36

305.74

mg/l

1.18

250

1419

ILD, hospital admissions

254

1.34

0.88

1.1

279.03

296.77

mg/l

0.27

217

Injuries to the elbow and forearm

281

2306

1.10

0.87

1.1

258.86

261.73

mg/l

0.07

236

2046

Atrial fibrillation and flutter

104

576

1.18

0.87

1.1

342.58

280.58

mg/l

0.34

509

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

671

0.82

0.86

1.2

1.1

320.99

247.57

mg/l

0.62

586

Malignant neoplasm, wide definition for exclusion

387

2104

1.09

0.86

1.1

341.67

258.49

mg/l

1.68

336

1855

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

387

2104

1.09

0.86

1.1

341.67

258.49

mg/l

1.68

336

1855

Other interstitial pulmonary diseases

255

1.34

0.86

1.1

279.03

295.97

mg/l

0.26

218

Parodontitis and operation codes

326

2319

1.09

0.85

1.1

274.01

280.12

mg/l

0.20

293

2027

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

278

1.29

0.85

1.0

1.1

361.24

299.02

mg/l

0.74

251

Other maternal disorders predominantly related to pregnancy

281

1604

1.10

0.84

1.1

210.49

224.26

mg/l

0.72

253

1386

Galactorrhea

1.95

0.84

1.3

1.1

150.83

193.46

mg/l

—

Interstitial lung disease

256

1.33

0.84

1.1

279.03

295.46

mg/l

0.25

219

Interstitial lung disease endpoints

256

1.33

0.84

1.1

279.03

295.46

mg/l

0.25

219

Bicipital tendinitis

1.60

0.84

1.1

1.0

273.57

292.25

mg/l

0.12

Sulfonylureas

491

0.80

0.84

1.0

1.1

343.15

309.10

mg/l

0.58

433

Disorders of continuity of bone

265

1.32

0.84

1.1

208.36

275.95

mg/l

2.28

235

Trigger finger

309

1.30

0.83

1.1

316.71

261.56

mg/l

0.62

267

Contraceptive management

208

1310

1.12

0.82

1.1

233.69

262.03

mg/l

1.38

184

1136

Gestational diabetes (for exclusion)

214

1359

1.12

0.82

1.1

203.14

201.86

mg/l

0.05

198

1189

Loose body in joint

1.75

0.82

1.1

371.50

306.54

mg/l

—

Suggestive for eosinophilic asthma

214

1.36

0.82

1.0

1.1

223.52

300.83

mg/l

2.35

182

Cholecystitis

266

1.32

0.82

1.2

1.1

330.59

290.49

mg/l

0.19

227

Early syphilis

1.89

0.82

1.2

1.1

293.33

261.00

mg/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

386

2105

1.08

0.82

1.1

341.23

258.39

mg/l

1.66

335

1856

Gout, FINNGEN

480

1.23

0.81

1.0

1.1

456.09

323.10

mg/l

1.16

418

Postprocedural musculoskeletal disorders, not elsewhere classified

138

1.45

0.81

1.2

1.0

253.27

292.31

mg/l

0.50

118

Torsion of ovary, ovarian pedicle and fallopian tube

1.61

0.81

1.1

1.0

217.38

211.71

mg/l

0.07

Benign leiomyoma with endometriosis

355

1.27

0.81

1.1

282.86

238.20

mg/l

0.68

314

Certain conditions originating in the perinatal period

330

1.27

0.81

1.1

230.69

204.11

mg/l

0.19

285

Glomerular disorders in diseases classified elsewhere

267

1.31

0.80

1.1

291.08

288.47

mg/l

0.02

228

Benign neoplasm: Short bones of upper limb

1.83

0.79

1.0

1.1

155.17

226.54

mg/l

—

Other interventions on the root canals of the tooth

1.67

0.79

1.0

1.1

192.25

230.55

mg/l

—

Placenta praevia

199

0.65

0.78

1.0

1.1

206.23

223.12

mg/l

0.19

170

Amiodarone users

175

0.63

0.78

1.0

1.1

317.55

304.75

mg/l

0.11

148

Alcoholic liver disease

208

1.35

0.77

1.1

281.27

312.43

mg/l

0.59

183

Malignant neoplasm of bladder

100

0.50

0.77

1.2

1.0

225.80

290.14

mg/l

—

Nasal polyp

484

1.22

0.77

1.0

1.1

257.17

283.67

mg/l

0.54

418

Personal history of other diseases and conditions

455

1.23

0.76

1.1

207.38

219.25

mg/l

0.28

408

Benign neoplasm: Short bones of upper limb

1.77

0.76

1.0

1.1

155.17

232.79

mg/l

—

Mandibular retrognathia

243

1.32

0.75

1.1

212.00

236.58

mg/l

0.45

217

222

1.32

0.75

1.0

1.1

317.27

296.58

mg/l

0.25

195

Hypertrophy of breast in women and men

641

1.19

0.75

1.2

1.1

284.31

236.96

mg/l

0.35

558

Artificial joint operation, meniscal resection

317

1941

1.09

0.74

1.1

280.09

293.86

mg/l

0.40

277

1706

LSIL lesion of the cervix uteri, vagina or vulva

559

1.20

0.74

1.0

1.1

194.23

211.32

mg/l

0.82

495

Benign neoplasm: Liver

1.67

0.74

1.0

180.22

219.84

mg/l

—

Macular pucker

227

1.32

0.74

1.1

320.83

284.82

mg/l

0.38

202

Delivery, wide proxy

118

719

0.87

0.73

1.1

204.89

222.28

mg/l

0.67

100

615

Ischaemic heart disease, wide definition

242

1378

1.10

0.73

1.1

285.27

308.39

mg/l

0.76

201

1213

Aortic aneurysm

384

0.77

0.73

1.0

1.1

279.45

331.98

mg/l

0.91

337

Separation of retinal layers (serosa)

100

1.50

0.73

1.1

233.93

293.56

mg/l

1.12

Other bursal cyst

2.01

0.73

1.0

1.1

226.60

276.95

mg/l

—

Mental and behavioural disorders due to tobacco

228

1.32

0.72

1.1

291.92

284.32

mg/l

0.07

199

Hypertrophy of breast

570

1.19

0.72

1.2

1.1

273.65

224.59

mg/l

0.32

496

Parapsoriasis

1.80

0.72

1.0

1.1

158.14

240.03

mg/l

—

Heart failure, not strict

237

1487

1.10

0.72

1.1

274.71

301.39

mg/l

1.14

207

1309

Other benign neoplasms of skin

110

941

1.15

0.72

1.0

1.1

287.84

260.25

mg/l

0.46

832

Benign lipomatous neoplasm

764

1.17

0.72

1.0

1.1

254.17

263.75

mg/l

0.27

678

Other salmonella infections

1.55

0.72

1.1

1.0

232.08

242.44

mg/l

0.16

Burn and corrosion confined to eye and adnexa

1.63

0.72

1.0

1.1

238.09

263.39

mg/l

0.29

Idiopathic pulmonary fibrosis

110

0.54

0.72

1.3

1.1

205.67

286.30

mg/l

—

Benign leiomyoma with endometriosis

362

1.24

0.71

1.1

282.86

236.96

mg/l

0.71

321

Benign neoplasm: Liver

1.59

0.71

1.0

180.22

219.13

mg/l

—

IBD patients in KELA-register

103

896

1.15

0.71

1.0

1.1

224.11

254.15

mg/l

1.57

800

Parodontitis or operation codes

345

2356

1.08

0.70

1.1

273.70

280.51

mg/l

0.23

309

2062

Malignant neoplasm of testis

1.72

0.70

1.0

1.1

272.86

285.53

mg/l

—

Unstable angina pectoris

588

1.17

0.70

1.1

324.69

319.25

mg/l

0.08

518

Primary open-angle glaucoma

496

1.20

0.69

1.1

318.49

306.31

mg/l

0.15

436

Melanocytic naevi of scalp and neck

1.53

0.68

1.0

1.1

312.33

218.29

mg/l

—

Hallux valgus (acquired)

106

669

1.15

0.68

1.1

301.12

265.23

mg/l

0.35

581

Maternal care related to the fetus and amniotic cavity and possible delivery problems

233

1251

1.10

0.68

1.1

189.02

226.26

mg/l

4.25

204

1081

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

353

2318

0.93

0.68

1.1

313.53

273.04

mg/l

1.59

311

2044

Seborrhoeic dermatitis

231

1.30

0.67

1.3

1.1

337.50

283.90

mg/l

0.40

196

Puerperal sepsis

365

1.23

0.67

1.0

1.1

211.61

234.31

mg/l

0.62

324

Nontoxic goitre/thyroid nodule

758

0.84

0.67

1.1

272.88

254.65

mg/l

0.25

660

323

1.23

0.67

1.1

314.20

316.44

mg/l

0.03

286

Parodontitis

344

2357

1.08

0.66

1.1

273.70

280.51

mg/l

0.23

309

2062

Disorders of gallbladder, biliary tract and pancreas

388

2333

1.07

0.66

1.1

265.26

275.87

mg/l

0.39

336

2047

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

144

877

1.12

0.66

1.0

1.1

376.11

281.27

mg/l

0.91

119

779

Ulcerative colitis, NAS

457

1.21

0.66

1.1

231.12

261.12

mg/l

1.00

404

Other specified and unspecified disorders of eye and adnexa

1.52

0.66

1.1

261.38

226.46

mg/l

0.43

Smoking dependency

232

1.30

0.66

1.1

291.92

283.14

mg/l

0.09

201

Alcohol dependence

781

1.15

0.65

1.1

261.65

302.67

mg/l

1.45

697

Bitten or struck by other mammals

385

1.22

0.65

1.1

212.82

242.90

mg/l

1.42

336

Peritonsillar abscess

782

1.15

0.64

1.1

229.40

238.19

mg/l

0.27

681

Coxarthrosis [arthrosis of hip](FG)

139

897

1.12

0.64

1.1

306.34

304.28

mg/l

0.04

117

780

Tumor necrosis factor alpha inhibitors

523

1.19

0.64

1.1

215.48

254.89

mg/l

1.14

464

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

215

1721

1.09

0.63

1.1

203.50

222.94

mg/l

1.55

201

1496

Persons encountering health services in circumstances related to reproduction

273

1709

1.08

0.63

1.1

247.46

269.58

mg/l

0.92

249

1482

Blepharochalasis

561

1.18

0.63

1.1

304.73

282.70

mg/l

0.27

486

Any event in cancer register

411

2285

1.07

0.62

1.1

330.39

253.65

mg/l

1.62

355

2010

Personal history of malignant neoplasm

1.52

0.62

1.2

1.1

179.08

245.96

mg/l

0.78

5-aminosalicylic acid

729

1.15

0.62

1.0

1.1

269.57

257.63

mg/l

0.12

656

Thyrotoxicosis with diffuse goitre

424

1.20

0.62

1.1

252.18

238.74

mg/l

0.18

371

Erosion and ectropion of cervix uteri

1.59

0.62

1.0

247.30

233.96

mg/l

—

Mental retardation, excluding more controls

1.49

0.61

1.2

1.1

218.82

246.72

mg/l

0.35

Corneal scars and opacities

1.61

0.61

1.1

1.0

237.25

253.13

mg/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

325

1.23

0.60

1.0

1.1

251.18

257.60

mg/l

0.12

291

Other benign neoplasms of skin

110

975

1.13

0.60

1.0

1.1

287.84

265.39

mg/l

0.35

857

Other congenital malformations of male genital organs

0.00

0.60

0.0

1.1

—

248.31

—

Inflammatory bowel disease, strict (require KELA)

103

910

1.13

0.60

1.0

1.1

224.11

253.86

mg/l

1.55

811

Endometriosis of ovary

609

1.16

0.60

1.0

1.1

233.05

220.27

mg/l

0.22

538

Other and unspecified injuries of lower leg

227

1.28

0.60

1.0

1.1

253.45

249.92

mg/l

0.03

191

Delivery

146

858

0.90

0.59

1.1

216.07

228.09

mg/l

0.39

126

738

Schizophrenia or delusion

135

1213

1.11

0.59

1.0

1.1

222.89

262.75

mg/l

2.22

114

1072

Seropositive rheumatoid arthritis, wide

658

1.16

0.59

1.1

306.36

263.21

mg/l

0.48

585

Insulin, combination of fast acting with intermediate-acting or long-acting

205

1734

1.09

0.59

1.1

328.09

278.75

mg/l

1.50

173

1537

Kela-code for severe mental illness

155

1405

1.10

0.58

1.0

1.1

235.71

260.57

mg/l

1.07

132

1247

Erysipelas

158

1307

1.10

0.58

1.1

377.01

284.81

mg/l

0.91

135

1165

Angina pectoris

161

985

1.10

0.58

1.1

290.56

324.50

mg/l

1.11

136

875

Biguanides

331

2181

0.93

0.58

1.1

308.67

271.97

mg/l

1.40

290

1916

Leiomyoma of uterus

202

1042

1.09

0.57

1.1

250.66

225.72

mg/l

0.89

176

920

Nontoxic diffuse goitre

1.48

0.57

1.3

1.1

204.38

264.50

mg/l

—

Complications following abortion and ectopic and molar pregnancy

1.49

0.57

1.1

1.0

243.33

233.54

mg/l

0.08

Schizophrenia, schizotypal and delusional disorders

135

1217

1.11

0.57

1.0

1.1

222.89

263.56

mg/l

2.29

114

1076

Chronic periodontitis, including avohilmo

340

2356

1.07

0.57

1.1

274.84

280.54

mg/l

0.19

305

2061

Olecranon bursitis

1.43

0.56

1.1

262.79

294.40

mg/l

0.50

Effects of foreign body entering through natural orifice

830

1.13

0.56

1.1

316.34

270.91

mg/l

0.25

731

Other vitreous opacities

1.51

0.56

1.0

1.1

243.36

246.50

mg/l

0.04

Malignant neoplasm of respiratory system and intrathoracic organs

302

1.22

0.56

1.0

1.1

414.14

303.80

mg/l

1.32

257

Bicuspidal aortic valve syndrome

0.56

1.0

1.1

314.00

289.46

mg/l

—

Arterial embolism and thrombosis

0.56

1.0

1.1

192.20

266.44

mg/l

—

Diabetic nephropathy

298

1.23

0.55

1.1

323.37

310.50

mg/l

0.12

256

Other/unspecified seropositive rheumatoid arthritis

653

1.15

0.55

1.1

308.17

263.40

mg/l

0.49

580

Congenital malformations of breast

1.51

0.54

1.1

201.56

199.10

mg/l

—

Acute pancreatitis

477

1.18

0.54

1.1

253.35

289.85

mg/l

0.75

412

Nonischemic cardiomyopathy

126

0.63

0.54

1.0

222.38

316.56

mg/l

—

111

Foreign body or object entering through skin

204

1.28

0.54

1.1

262.52

291.30

mg/l

0.48

173

Pregnancy hypertension

198

1644

1.09

0.54

1.1

202.37

215.71

mg/l

0.90

184

1433

Alcohol-induced chronic pancreatitis

151

1.33

0.54

1.1

260.00

325.41

mg/l

1.05

132

Other follicular disorders

240

1.25

0.53

1.0

1.1

278.25

262.95

mg/l

0.14

202

Thyrotoxicosis

730

1.14

0.53

1.1

253.93

246.06

mg/l

0.13

647

LSIL lesion of the cervix uteri

469

1.17

0.53

1.0

1.1

190.19

205.08

mg/l

0.62

417

Benign neoplasm: Liver/bile ducts

1.46

0.53

1.0

180.22

230.20

mg/l

—

Coronary angioplasty

576

0.87

0.52

1.1

285.67

320.82

mg/l

0.77

510

Benign neoplasm: Liver/bile ducts

1.43

0.52

1.0

180.22

220.06

mg/l

—

Benign neoplasm: Skin, unspecified

0.62

0.52

1.3

1.1

587.33

243.02

mg/l

—

635

1.14

0.52

1.1

300.22

309.15

mg/l

0.08

559

1.45

0.52

1.1

161.86

204.54

mg/l

—

Other disorders of breast and lactation associated with childbirth

1.41

0.51

1.0

195.11

185.09

mg/l

—

Salpingitis and oophoritis

508

1.16

0.51

1.1

204.47

229.45

mg/l

0.90

441

Single spontaneous delivery

146

854

0.91

0.51

1.1

217.83

228.21

mg/l

0.33

126

734

Infective dermatitis

278

1.22

0.51

1.1

255.25

274.76

mg/l

0.36

241

Type 1 diabetes

109

978

1.11

0.51

1.1

303.29

251.74

mg/l

1.14

874

Skin changes due to chronic exposure to nonionizing radiation

569

1.15

0.51

1.0

1.1

315.10

310.14

mg/l

0.04

503

Ovarian hyperstimulation (induction)

1.39

0.50

1.1

191.56

199.15

mg/l

—

Diverticular disease of intestine

208

1278

1.08

0.50

1.1

266.15

304.78

mg/l

2.01

192

1109

Malignant neoplasm of bronchus and lung

261

1.22

0.49

1.0

1.1

386.14

312.67

mg/l

0.71

221

Psoriasis

868

1.12

0.49

1.0

1.1

256.19

261.32

mg/l

0.08

761

Erythema intertrigo

1.56

0.49

1.6

1.0

286.14

274.70

mg/l

—

Other menopausal disorders

100

515

1.12

0.48

1.1

225.46

252.43

mg/l

0.87

447

Cerebral palsy

1.53

0.48

1.1

208.00

252.13

mg/l

—

Schizoid personality disorder

1.53

0.48

1.0

1.1

222.29

261.50

mg/l

—

Diseases of arteries, arterioles and capillaries

179

1232

1.08

0.48

1.1

338.78

299.90

mg/l

0.35

148

1095

Other appendicitis

235

1.24

0.48

1.1

230.26

288.57

mg/l

1.99

201

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

643

1.14

0.48

1.1

304.17

262.40

mg/l

0.44

570

Blood alcohol or alcohol intoxication level

1.48

0.47

1.2

1.1

265.30

267.16

mg/l

—

Spontaneous abortion

207

1308

1.08

0.46

1.1

222.70

222.80

mg/l

0.00

181

1144

Other fall from one level to another

767

1.12

0.46

1.1

252.29

257.22

mg/l

0.09

672

Single delivery by forceps and vacuum extractor

510

0.88

0.46

1.1

182.75

205.26

mg/l

1.24

443

Pollen allergy

844

1.11

0.46

1.1

211.76

224.88

mg/l

0.56

741

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.43

0.46

1.0

1.1

272.86

284.18

mg/l

—

Other disorders of prostate

1.43

0.46

1.0

296.71

339.30

mg/l

—

Acute pancreatitis (for exclusion)

486

1.15

0.45

1.1

253.35

289.58

mg/l

0.74

421

Malignant neoplasm of stomach

0.61

0.45

1.0

1.1

582.60

284.89

mg/l

—

Allergic urticaria

264

1.21

0.45

1.2

1.1

187.75

244.62

mg/l

2.22

224

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.59

0.45

1.0

582.60

267.86

mg/l

—

Diabetic nephropathy, excluding more controls

259

1.19

0.44

1.1

323.37

333.18

mg/l

0.08

224

Viral agents as the cause of diseases classified to other chapters

1.38

0.44

1.0

1.1

240.57

233.30

mg/l

—

Use of levodopa decarbox-comt-inhibitor

1.37

0.44

2.1

1.1

338.00

283.61

mg/l

—

Acute alcohol intoxication

752

1.12

0.44

1.2

1.1

234.64

279.65

mg/l

2.67

665

Benign neoplasm: Skin, unspecified

0.66

0.42

1.3

1.1

587.33

233.82

mg/l

—

Unspecified misadventure during surgical and medical care

122

1.31

0.42

1.0

1.1

243.94

267.28

mg/l

0.22

104

Malignant neoplasm

362

2039

1.05

0.42

1.1

354.06

261.15

mg/l

1.81

314

1800

Dislocation, sprain and strain of joints and ligaments of head

131

1.30

0.42

1.0

1.1

215.92

256.76

mg/l

0.51

108

Leiomyoma of uterus

241

1286

1.07

0.42

1.1

256.34

238.40

mg/l

0.58

212

1130

Evidence of alcohol involvement determined by blood alcohol level

1.52

0.41

1.0

1.1

255.20

252.96

mg/l

—

Scoliosis

240

1.21

0.41

1.1

1.0

231.57

238.15

mg/l

0.05

208

Xanthelasma of eyelid

0.00

0.41

0.0

1.1

—

215.25

—

Combined immunodeficiencies

0.00

0.41

0.0

1.0

—

223.00

—

In situ neoplasms

101

918

1.10

0.41

1.1

280.37

250.16

mg/l

0.45

814

Superficial injury of neck

1.36

0.41

1.3

1.1

205.50

220.04

mg/l

—

Diabetes medication

413

2629

0.95

0.41

1.1

294.29

264.08

mg/l

1.55

360

2320

Other adrenocortical overactivity

0.00

0.41

0.0

1.1

—

224.76

—

Sequelae of injuries of lower limb

268

1.20

0.40

1.0

1.1

237.94

274.92

mg/l

0.96

233

Conduction disorders

573

1.12

0.40

1.1

304.32

293.02

mg/l

0.11

500

Thyrotoxicosis, other and/or unspecified

577

1.13

0.40

1.1

237.93

244.63

mg/l

0.12

510

Postpartum care and examination

506

1.11

0.40

1.1

198.04

202.34

mg/l

0.12

423

Thoracic aortic aneurysm

260

0.81

0.40

1.0

1.1

289.07

329.25

mg/l

0.44

227

Insulin, fast-acting

126

1159

1.09

0.40

1.1

279.95

260.20

mg/l

0.63

105

1031

Congenital deformities of hip

1.31

0.39

1.1

124.00

179.31

mg/l

—

Post-traumatic wound infection, not elsewhere classified

1.31

0.39

1.0

1.1

235.88

236.11

mg/l

—

Other congenital malformations of peripheral vascular system

1.43

0.39

1.0

1.1

354.00

198.07

mg/l

—

Long labour

107

1021

0.91

0.39

1.0

1.1

203.84

206.12

mg/l

0.10

892

Cholelithiasis, broad definition with cholecystitis

319

2076

1.05

0.39

1.1

266.95

272.57

mg/l

0.16

275

1822

Congenital malformations of cardiac chambers and connections

0.00

0.39

0.0

1.0

—

250.53

—

Actinic keratosis

540

1.13

0.39

1.0

1.1

323.91

314.27

mg/l

0.07

478

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

551

1.12

0.38

1.0

1.1

241.52

259.01

mg/l

0.36

482

Ulcer of vagina/vulva

1.37

0.38

1.0

1.1

172.31

199.75

mg/l

—

Psoriatic and enteropathic arthropathies

307

1.17

0.38

1.0

1.1

248.68

272.22

mg/l

0.40

265

Premature rupture of membranes

103

828

0.91

0.38

1.1

190.13

209.58

mg/l

1.32

724

Melanocytic naevi of scalp and neck

1.35

0.38

1.0

1.1

312.33

222.35

mg/l

—

COPD, hospital admissions 1, only main diagnosis

521

0.88

0.38

1.1

418.24

316.59

mg/l

0.31

459

Other endocrine disorders

163

1.24

0.38

1.1

182.20

215.37

mg/l

0.55

141

Other diseases of intestine

252

1.19

0.37

1.0

1.1

325.28

297.33

mg/l

0.23

212

Motorcycle rider injured in other and unspecified transport accidents

197

1.22

0.37

1.0

1.1

246.16

287.45

mg/l

0.80

167

In situ neoplasms

101

881

1.09

0.37

1.1

280.37

246.50

mg/l

0.52

783

Varicose veins

184

1302

1.07

0.37

1.1

275.11

283.05

mg/l

0.14

157

1140

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

346

1.16

0.36

1.0

1.1

251.18

273.52

mg/l

0.51

303

Mild mental retardation

1.27

0.36

1.2

1.0

222.78

252.13

mg/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.27

0.36

1.1

236.78

259.68

mg/l

—

Haemorrhagic and haematological disorders of fetus and newborn

1.39

0.36

1.1

156.60

185.11

mg/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

583

1.12

0.35

1.0

1.1

225.34

259.17

mg/l

1.57

513

Pleural effusion

263

1.18

0.35

1.1

272.21

304.56

mg/l

0.47

224

All dysplastic lesions of the cervix uteri, vagina or vulva

141

1304

1.08

0.35

1.0

1.1

198.34

208.68

mg/l

0.61

121

1148

Burns and corrosions of external body surface, specified by site

347

1.15

0.35

1.0

1.1

220.62

265.35

mg/l

1.33

300

Malignant neoplasm of mesothelium and soft tissue

0.63

0.35

1.0

1.1

295.40

245.81

mg/l

—

Acute nasopharyngitis (common cold)

401

1.14

0.35

1.0

1.1

253.30

283.37

mg/l

1.04

355

Redundant prepuce, phimosis and paraphimosis

609

1.11

0.35

1.1

334.98

332.71

mg/l

0.02

545

Fracture of femur

390

0.87

0.35

1.0

1.1

327.40

307.68

mg/l

0.09

334

Idiopathic thrombocytopenic purpura

1.37

0.34

1.2

1.1

214.00

222.83

mg/l

—

Congenital malformations of heart and great arteries

428

1.13

0.34

1.0

1.1

215.87

262.59

mg/l

2.07

370

Valvular heart disease excluding rheumatic fever

118

931

0.93

0.34

1.1

305.59

295.70

mg/l

0.15

102

824

Sub-endpoint used in defining T1D endpoints

111

1009

1.08

0.34

1.1

301.46

255.94

mg/l

0.96

893

Fracture of shoulder and upper arm

1012

0.92

0.34

1.1

264.61

257.85

mg/l

0.15

898

Polyp of the female genital tract

105

663

0.92

0.33

1.0

1.1

251.08

242.84

mg/l

0.14

583

Maternal care for cervical incompetence

109

1.29

0.33

1.3

1.1

160.56

239.61

mg/l

—

Ulcerative colitis (strict definition, require KELA)

605

1.11

0.33

1.0

1.1

224.72

257.60

mg/l

1.56

534

Pure hyperglyceridaemia

1.31

0.33

1.2

1.0

373.83

262.12

mg/l

—

Other disorders of iris and ciliary body

1.31

0.33

1.2

1.1

281.50

219.92

mg/l

—

Benign lipomatous neoplasm

816

1.09

0.33

1.0

1.1

254.17

266.80

mg/l

0.38

716

Inguinal hernia

189

1351

0.94

0.33

1.1

298.67

294.95

mg/l

0.08

166

1195

Iron deficiency anaemia secondary to blood loss (chronic)

341

1.14

0.32

1.2

1.1

244.26

267.77

mg/l

0.43

293

Cholelithiasis

304

2037

1.05

0.32

1.1

267.21

272.87

mg/l

0.15

264

1785

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

665

1.10

0.31

1.0

1.1

220.73

258.17

mg/l

1.97

590

Major anomalies of jaw size

1.31

0.30

1.2

1.1

173.27

243.82

mg/l

2.51

Abscess of anal and rectal regions

259

1.16

0.29

1.1

297.00

296.84

mg/l

0.00

221

Coronary atherosclerosis

169

1154

0.94

0.29

1.1

311.22

317.88

mg/l

0.12

138

1026

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

1.25

0.29

1.0

1.1

203.86

200.46

mg/l

—

1.31

0.29

1.0

1.1

334.36

243.46

mg/l

0.44

COPD

741

1.08

0.29

1.1

367.78

313.76

mg/l

0.29

654

Dislocation, sprain and strain of joints and ligaments of thorax

1.32

0.28

1.2

1.1

298.80

245.42

mg/l

—

Insulin, fast-acting (human)

554

0.90

0.27

1.1

256.57

254.51

mg/l

0.03

492

Major coronary heart disease event excluding revascularizations

150

1097

0.94

0.27

1.1

320.44

321.89

mg/l

0.02

130

972

Wide developmental disorders

119

0.75

0.27

1.1

161.44

236.33

mg/l

—

103

Idiopathic urticaria

1.23

0.27

1.3

1.1

223.12

219.48

mg/l

—

Major coronary heart disease event

171

1203

0.95

0.27

1.1

303.52

314.77

mg/l

0.24

151

1065

Insulin, fast-acting or short human

126

1184

1.06

0.27

1.1

279.95

262.80

mg/l

0.52

105

1049

Benign neoplasm of middle ear and respiratory system

159

1.20

0.26

1.1

1.0

326.08

264.67

mg/l

0.52

138

Benign neoplasm: Conjunctiva

0.69

0.26

1.0

1.1

200.40

250.67

mg/l

—

Benign neoplasm: Conjunctiva

0.69

0.26

1.0

1.1

200.40

237.63

mg/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.30

0.26

1.3

1.0

378.30

257.59

mg/l

—

Fracture of skull and facial bones

693

1.08

0.26

1.1

386.18

266.09

mg/l

0.63

617

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

329

1.13

0.26

1.0

1.1

180.18

213.81

mg/l

1.56

291

Family history of malignant neoplasm

348

1.12

0.26

1.0

1.1

319.79

234.48

mg/l

0.59

307

Atrophic disorders of skin

367

1.12

0.25

1.1

265.03

249.65

mg/l

0.15

321

Other (not insulin) diabetes medications

353

2204

0.97

0.25

1.1

306.84

271.16

mg/l

1.43

308

1941

Hernia

367

2405

1.04

0.25

1.1

283.48

279.63

mg/l

0.07

329

2110

Acute alcohol intoxication, ICD10

655

1.08

0.25

1.2

1.1

229.30

268.76

mg/l

2.11

576

Lactose intolerance, other/unspecified

1.23

0.25

1.1

167.11

204.92

mg/l

—

Supervision of high-risk pregnancy

111

629

1.07

0.25

1.1

229.36

210.51

mg/l

0.20

529

Coxarthrosis, primary, with hip surgery

865

0.93

0.25

1.0

1.1

308.77

309.95

mg/l

0.02

761

Coxarthrosis

129

825

1.06

0.25

1.1

305.39

306.08

mg/l

0.01

109

716

Complications associated with artificial fertilization

1.19

0.24

1.1

191.56

186.13

mg/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

637

1.08

0.24

1.1

236.43

247.03

mg/l

0.18

562

Eustachian salpingitis and obstruction

321

1.12

0.24

1.1

277.80

231.39

mg/l

0.82

281

Lactose intolerance

1.27

0.24

1.1

173.91

207.79

mg/l

0.78

Pedestrian injured in collision with pedal cycle

1.28

0.24

1.1

208.50

227.93

mg/l

—

Polyarthritis, unspecified

1.28

0.24

1.1

175.00

285.57

mg/l

—

Failed induction of labour

275

0.87

0.23

1.0

1.1

192.83

203.38

mg/l

0.26

238

Malignant neoplasm of skin

136

970

1.06

0.23

1.1

401.72

297.77

mg/l

0.91

113

856

Chronic viral hepatitis

190

1.16

0.23

1.1

207.59

258.19

mg/l

1.53

162

Alcohol abuse counselling and surveillance

1.28

0.23

1.0

1.1

318.80

266.81

mg/l

—

Non-rheumatic valve diseases

118

911

0.94

0.22

1.1

305.59

298.22

mg/l

0.11

102

806

Type 2 diabetes

406

2340

1.03

0.22

1.1

293.64

266.91

mg/l

1.47

355

2065

Type 2 diabetes, definitions combined, including avohilmo

357

2180

0.97

0.22

1.1

299.95

268.27

mg/l

1.65

314

1923

Foreign body on external eye

477

1.09

0.22

1.1

416.05

295.21

mg/l

0.37

419

Postpartum haemorrhage due to anatomy

493

0.91

0.22

1.0

1.1

178.49

192.41

mg/l

0.61

437

Contusion of ankle

124

0.81

0.21

1.1

303.10

220.86

mg/l

—

106

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.1

—

266.40

—

Malaria

0.00

0.21

0.0

1.1

—

259.70

—

Heart failure and antihypertensive medication

385

1.08

0.21

1.1

232.04

317.64

mg/l

2.56

341

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.1

—

223.17

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

296

1.12

0.21

1.1

278.40

315.00

mg/l

0.87

255

Injury of muscle and tendon at lower leg level

411

1.10

0.21

1.0

1.1

317.35

290.12

mg/l

0.46

352

Suppurative and necrotic conditions of lower respiratory tract

104

0.77

0.21

1.1

1.0

325.50

298.47

mg/l

—

Other and unspecified nail disorders

1.16

0.21

1.0

1.1

196.60

225.82

mg/l

—

Bursitis of shoulder

1.16

0.21

1.6

1.0

350.20

275.66

mg/l

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.1

—

303.77

—

Type 2 diabetes, strict (exclude DM1)

351

2158

0.97

0.20

1.1

296.37

270.05

mg/l

1.26

308

1900

Type 1 diabetes, wide definition

872

0.94

0.20

1.1

258.99

248.07

mg/l

0.25

780

Foreign body in alimentary tract

145

1.17

0.20

1.1

177.35

267.25

mg/l

2.73

126

ILD medications: pirfenidone

0.00

0.20

0.0

1.0

—

282.21

—

Melanocytic naevi of other and unspecified parts of face

155

0.84

0.20

1.2

1.1

271.62

244.19

mg/l

0.17

134

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

136

1.18

0.20

1.1

514.25

224.94

mg/l

0.55

117

Oral leukoplakia and related diseases

108

1.21

0.20

1.2

1.1

270.62

282.68

mg/l

0.12

Cyst of Bartholin Gland

114

0.79

0.20

1.1

192.78

217.77

mg/l

—

Ulcer of lower limb, not elsewhere classified

250

1.12

0.19

1.1

621.63

316.28

mg/l

0.41

213

Presence of cardiac and vascular implants and grafts

667

0.94

0.19

1.1

318.45

330.49

mg/l

0.18

593

Other chronic obstructive pulmonary disease

706

1.06

0.19

1.1

374.51

315.53

mg/l

0.30

622

Acute posthaemorrhagic anaemia

1.15

0.19

1.2

1.1

256.83

251.76

mg/l

—

Other viral hepatitis

222

1.13

0.19

1.1

208.00

268.42

mg/l

2.32

192

Superficial injury of ankle and foot

443

1.08

0.19

1.1

242.80

227.29

mg/l

0.27

386

Poor fetal growth

589

1.07

0.18

1.2

1.1

194.49

198.46

mg/l

0.15

524

Seropositive rheumatoid arthritis, strict definition

363

0.91

0.18

1.1

227.85

263.75

mg/l

0.80

317

Anorexia (incl.atypical)

242

1.12

0.18

1.1

1.0

243.86

204.50

mg/l

0.37

212

Pre-eclampsia or eclampsia

863

1.05

0.17

1.2

1.1

201.94

215.51

mg/l

0.67

752

Campylobacter enteritis

1.15

0.17

1.0

1.1

290.29

231.00

mg/l

—

Autism spe, excluding more controls

1.13

0.17

1.1

149.71

253.81

mg/l

—

Type 1 diabetes, wide definition, subgroup 1

844

0.95

0.17

1.1

260.40

250.16

mg/l

0.23

754

Insulin, intermediate and long-acting

169

1598

1.04

0.17

1.1

300.34

281.82

mg/l

0.64

143

1419

Dental caries 3 and operation codes, only avohilmo

146

704

1.04

0.16

1.0

1.1

245.00

254.76

mg/l

0.21

120

634

Type 2 diabetes, definitions combined

351

2146

0.98

0.16

1.1

296.37

270.13

mg/l

1.25

308

1893

Arthropod-borne viral fevers and viral haemorrhagic fevers

244

1.11

0.16

1.3

1.1

298.95

293.23

mg/l

0.04

209

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

102

733

0.95

0.16

1.0

1.1

318.22

289.42

mg/l

0.43

655

Childhood allergy (age < 16)

673

1.05

0.16

1.1

208.09

222.51

mg/l

0.24

589

467

1.07

0.15

1.0

1.1

191.48

195.72

mg/l

0.13

413

Medical treatment for female infertility

101

1054

0.96

0.15

1.1

182.80

203.36

mg/l

1.52

925

Insulin medication

205

1699

1.03

0.15

1.1

328.09

273.52

mg/l

1.76

173

1514

Other malignant neoplasms of skin (=non-melanoma skin cancer)

100

826

0.96

0.15

1.1

421.45

304.82

mg/l

0.74

730

Femoral hernia

1.13

0.15

1.0

1.1

173.89

242.72

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

342

1.08

0.15

1.0

1.1

180.18

205.06

mg/l

1.08

304

Haemorrhage in early pregnancy

124

1164

1.04

0.14

1.1

208.62

213.26

mg/l

0.11

116

1010

Autism

0.81

0.14

1.1

149.71

260.73

mg/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

372

0.92

0.14

1.0

1.1

295.40

247.15

mg/l

0.51

330

Benign neoplasm of middle ear and respiratory system

169

1.13

0.14

1.1

1.0

326.08

297.10

mg/l

0.20

145

Carcinoma in situ of cervix uteri

362

1.08

0.14

1.1

193.71

204.14

mg/l

0.25

317

Pre-eclampsia

812

1.05

0.14

1.2

1.1

204.34

215.34

mg/l

0.47

711

Other or unspecified ileus, impaction or obstruction

363

1.07

0.13

1.1

272.50

314.00

mg/l

0.78

309

Melanocytic naevi of other and unspecified parts of face

149

0.87

0.13

1.2

1.1

271.62

252.04

mg/l

0.12

130

Eating disorders

480

1.06

0.13

1.1

227.47

206.91

mg/l

0.24

415

Umbilical hernia

796

0.95

0.13

1.1

287.39

281.50

mg/l

0.05

701

Fracture of forearm

189

1722

1.03

0.12

1.1

269.64

263.21

mg/l

0.12

156

1517

Ulcerative colitis (strict definition, all Crohn cases excluded)

501

1.06

0.12

1.1

229.56

262.90

mg/l

1.40

440

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

423

1.06

0.12

1.1

360.89

288.67

mg/l

0.94

384

Acute appendicitis, with complications

560

1.05

0.12

1.1

437.92

274.79

mg/l

0.92

482

Clear cell adenocarcinoma of kidney

1.18

0.12

1.3

1.1

378.30

306.08

mg/l

—

Postpartum hemorraghe, all women as controls

119

1225

0.97

0.12

1.1

199.77

202.23

mg/l

0.06

101

1079

Graves disease, strict definition

317

1.07

0.12

1.1

230.96

229.78

mg/l

0.01

280

COPD, hospital admissions 3, with asthma pneumonia sepsis

369

1.06

0.11

1.2

1.1

457.51

322.42

mg/l

0.37

323

All dysplastic lesions of the cervix uteri

123

1189

1.03

0.11

1.0

1.1

193.73

205.57

mg/l

0.71

104

1046

Toxic effect of ethanol

126

0.87

0.11

1.0

1.1

180.45

271.16

mg/l

1.63

104

Supervision of normal pregnancy

112

662

0.97

0.11

1.1

197.00

209.69

mg/l

0.60

557

Lichen planus, including avohilmo

416

1.06

0.11

1.0

1.1

322.08

279.59

mg/l

0.39

360

Postpartum haemorrhage

119

1067

0.97

0.10

1.1

199.77

206.43

mg/l

0.19

101

930

D07AA Corticosteroids, weak (group I)

593

1.04

0.10

1.0

1.1

224.93

235.42

mg/l

0.19

521

Calcific aortic valvular stenosis, operated

404

0.94

0.10

1.0

1.1

294.42

332.51

mg/l

0.53

354

Calcific aortic valvular stenosis

404

0.94

0.10

1.0

1.1

294.42

332.51

mg/l

0.53

354

Postmenopausal bleeding

373

0.96

0.10

1.1

270.34

272.96

mg/l

0.02

324

Labour and delivery complicated by fetal stress [distress]

134

919

0.97

0.10

1.1

192.30

198.57

mg/l

0.24

121

796

Diabetes mellitus in pregnancy

179

1134

1.02

0.10

1.1

197.03

201.74

mg/l

0.17

165

983

Calcific aortic valvular stenosis, including rheumatic fever

403

0.95

0.09

1.0

1.1

294.42

331.58

mg/l

0.52

353

Other and unspecified mental retardation

1.09

0.09

1.0

1.1

205.94

208.58

mg/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

403

0.95

0.09

1.0

1.1

294.42

331.58

mg/l

0.52

353

Operations 2 for CAVS

403

0.95

0.09

1.0

1.1

294.42

331.58

mg/l

0.52

353

Cleft lip, lip and palate or palate

1.06

0.09

1.0

1.1

302.00

211.49

mg/l

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

1.06

0.09

1.0

399.80

224.27

mg/l

—

Injury of muscle and tendon at forearm level

1.04

0.09

1.0

1.1

236.20

278.10

mg/l

—

Hernia of abdominal wall

126

1293

0.97

0.09

1.1

272.19

287.69

mg/l

0.20

110

1153

Pre-eclampsia or poor fetal growth

143

1393

1.02

0.09

1.2

1.1

199.49

207.80

mg/l

0.49

128

1219

Eating disorder

419

1.05

0.08

1.1

203.11

200.93

mg/l

0.02

361

Primary coxarthrosis, bilateral

518

1.04

0.08

1.1

337.13

302.49

mg/l

0.54

458

Intrahepatic Cholestasis of Pregnancy (ICP)

302

1.06

0.08

1.0

1.1

167.83

206.25

mg/l

1.98

268

Maxillary retrognathism

0.82

0.08

1.0

1.1

172.20

204.11

mg/l

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.83

0.08

1.0

415.80

229.85

mg/l

—

Carcinoma in situ of cervix uteri

371

1.05

0.08

1.1

193.71

207.67

mg/l

0.36

326

Other chronic obstructive pulmonary disease, including avohilmo

119

965

1.03

0.08

1.1

348.80

307.75

mg/l

0.26

100

846

Complications of labour and delivery

268

1518

0.98

0.08

1.1

216.96

221.03

mg/l

0.17

240

1313

Lesion of sciatic nerve

1.08

0.08

1.0

1.1

378.43

251.41

mg/l

—

Acute and transient psychotic disorders

391

1.05

0.08

1.0

1.1

220.55

263.87

mg/l

1.35

338

Other specified disorders of kidney and ureter

1.05

0.08

1.1

1154.00

235.03

mg/l

—

Crohn's disease of large intestine

164

0.91

0.08

1.0

1.1

231.80

265.35

mg/l

—

139

Other disorders of amniotic fluid and membranes

671

1.03

0.07

1.0

1.1

205.43

208.76

mg/l

0.10

584

Benign neoplasm of breast

303

1.06

0.07

1.2

1.1

250.93

221.66

mg/l

0.34

270

Ventral hernia

561

0.96

0.07

1.1

236.61

283.22

mg/l

1.09

491

Congenital malformations of ovaries, fallopian tubes and broad ligaments

215

1.07

0.07

1.1

330.06

204.30

mg/l

0.35

188

Alcohol abuse, main dg

510

1.04

0.07

1.2

1.1

228.63

272.76

mg/l

2.11

446

Other assisted single delivery

1.05

0.07

1.0

178.25

196.63

mg/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

688

1.03

0.07

1.0

1.1

287.55

272.35

mg/l

0.38

605

Cutaneous abscess, furuncle and carbuncle

876

1.03

0.07

1.1

275.23

252.98

mg/l

0.62

772

Pacemaker

505

0.96

0.07

1.0

1.1

271.45

319.85

mg/l

1.04

439

Parodontitis or/and operation codes

268

1570

1.01

0.07

1.1

257.88

256.28

mg/l

0.05

244

1367

Cholera

0.86

0.07

1.0

1.1

369.71

254.96

mg/l

—

Pyothorax

0.85

0.07

1.1

1.0

332.43

299.05

mg/l

—

Autism spe

0.82

0.07

1.1

149.71

248.52

mg/l

—

Wide developmental disorders, excluding more controls

1.05

0.07

1.1

161.44

246.39

mg/l

—

Coxarthrosis, primary

130

1105

1.02

0.07

1.1

307.75

303.87

mg/l

0.08

112

974

Respiratory and cardiovascular disorders specific to the perinatal period

0.88

0.07

1.0

1.1

462.88

215.11

mg/l

—

Rubella [German measles]

0.87

0.06

1.0

1.1

336.63

330.79

mg/l

—

Pedal cyclist injured in collision with motor vehicle

0.86

0.06

1.0

1.1

214.63

262.95

mg/l

—

Malignant neoplasm of prostate

436

0.97

0.06

1.1

347.02

376.13

mg/l

0.39

393

Gonarthrosis, primary, with knee surgery

121

968

1.02

0.06

1.0

1.1

267.05

316.87

mg/l

2.24

102

847

Total colectomy operation

105

0.86

0.06

1.0

224.44

249.08

mg/l

—

Total colectomy

105

0.86

0.06

1.0

224.44

249.08

mg/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

106

713

1.02

0.06

1.1

394.50

289.24

mg/l

0.73

637

Subarachnoid haemorrhage

197

1.07

0.06

1.0

304.95

282.41

mg/l

0.19

171

Postmenopausal atrophic vaginitis

397

0.97

0.06

1.1

247.74

275.61

mg/l

0.53

345

Glucagon-like peptide-1 (GLP-1) analogues

135

1090

1.02

0.06

1.1

317.10

304.03

mg/l

0.22

123

961

Dental caries 1 and operation codes, only avohilmo

118

581

1.02

0.06

1.1

249.06

265.07

mg/l

0.33

101

521

malignant neoplasm of male genital organs

470

1.03

0.06

1.1

359.20

369.99

mg/l

0.12

417

Abrasion of teeth

661

1.02

0.06

1.1

249.30

265.78

mg/l

0.34

590

Maternal care for other known or suspected fetal problems

133

838

1.02

0.05

1.1

182.86

207.07

mg/l

2.09

111

730

Maternal care for known or suspected abnormality of pelvic organs

121

850

0.98

0.05

1.1

185.93

217.78

mg/l

3.01

106

742

Embedded and impacted teeth

136

1138

1.02

0.05

1.1

199.17

221.29

mg/l

1.49

123

999

Other abnormal uterine and vaginal bleeding

497

0.98

0.05

1.1

217.69

224.58

mg/l

0.19

438

Maternal care for known or suspected fetal abnormality and damage

718

0.98

0.05

1.1

179.81

208.40

mg/l

2.15

626

Other and unspecified injuries of head

150

1.07

0.04

1.3

1.1

303.91

281.22

mg/l

0.16

125

Other blood glucose lowering drugs, excl. Insulins

322

0.96

0.04

1.1

329.36

299.76

mg/l

0.31

283

Wet age-related macular degeneration

186

1.06

0.04

1.2

1.1

323.40

291.99

mg/l

0.42

159

Obstructed labour due to malposition and malpresentation of fetus

107

1024

0.98

0.04

1.0

1.1

240.97

207.20

mg/l

0.40

894

Injuries to unspecified part of trunk, limb or body region

261

0.96

0.04

1.0

1.1

241.11

268.20

mg/l

0.42

222

Artificial opening status

109

0.92

0.04

1.2

1.1

243.80

278.18

mg/l

—

COPD related to multimorbidity

577

1.02

0.04

1.1

411.93

318.07

mg/l

0.37

509

Entropion and trichiasis of eyelid

121

1.07

0.03

1.3

1.0

257.00

265.46

mg/l

0.09

102

Seborrhoeic keratosis

438

1.03

0.03

1.1

352.57

288.67

mg/l

0.47

386

HSIL lesion of the cervix uteri

813

0.98

0.03

1.0

1.1

196.00

205.01

mg/l

0.35

717

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

103

701

1.01

0.03

1.0

1.1

402.07

289.38

mg/l

0.77

626

Lichen ruber planus, wide definition including periferal and oral lichen planus

510

1.02

0.02

1.0

1.1

299.85

270.72

mg/l

0.29

443

Pedal cyclist injured in other and unspecified transport accidents

341

1.03

0.02

1.1

251.11

267.84

mg/l

0.19

292

Benign neoplasm of ovary

421

1.02

0.02

1.0

1.1

319.77

236.27

mg/l

0.64

371

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

391

1.01

0.02

1.0

1.1

355.04

331.25

mg/l

0.30

349

Injury of unspecified body region

183

1.04

0.01

1.0

1.1

260.29

270.39

mg/l

0.10

159

Psoriasis vulgaris

543

1.01

0.01

1.0

1.1

279.70

265.19

mg/l

0.16

475

Congenital malformations of genital organs

391

1.02

0.01

1.1

273.45

218.73

mg/l

0.31

345

Diabetes mellitus

439

2614

1.00

0.00

1.1

291.89

262.49

mg/l

1.60

383

2308

Abnormal spermatozoa

206

0.97

0.00

1.1

465.86

344.99

mg/l

0.59

184

Other Crohn's disease

244

1.02

0.00

1.0

1.1

203.78

274.01

mg/l

1.56

209

Diabetes, varying definitions

434

2588

1.00

0.00

1.1

292.10

263.75

mg/l

1.49

376

2287

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

314

1.02

0.00

1.0

1.1

167.83

197.69

mg/l

1.41

278

Benign neoplasm of ovary

424

1.01

0.00

1.0

1.1

319.77

234.95

mg/l

0.65

378

Basal cell carcinoma, including avohilmo

112

886

1.00

0.00

1.1

412.13

302.79

mg/l

0.78

780

COPD, early/later onset

757

1.00

0.00

1.1

374.51

316.77

mg/l

0.29

664

Basal cell carcinoma

109

866

1.00

0.00

1.1

419.86

304.75

mg/l

0.81

761

Myocardial infarction, without ST-elevation

615

1.00

0.00

1.1

327.29

318.88

mg/l

0.12

541

Impacted teeth

872

1.00

0.00

1.1

200.65

219.50

mg/l

0.82

760

HSIL lesion of the cervix uteri, vagina or vulva

866

1.00

0.00

1.0

1.1

197.01

206.39

mg/l

0.41

760

Postpartum hemorraghe, parous women as controls

119

1040

1.00

0.00

1.1

199.77

201.38

mg/l

0.04

101

921

Pregnancy examination and test

554

1.00

0.00

1.1

189.15

205.24

mg/l

0.81

462

COPD, hospital admission 2, with asthma infections

473

0.99

0.00

1.2

1.1

439.56

321.22

mg/l

0.35

415

Tooth eruption problems

649

1.01

0.00

1.1

176.61

214.44

mg/l

2.13

564

Endovascular or surgical operations to intracerebral aneurysms

129

1.01

0.00

1.0

229.69

301.72

mg/l

1.29

113

Contact with machinery

275

0.98

0.00

1.2

1.1

334.59

318.65

mg/l

0.14

237

Viral hepatitis

251

1.00

0.00

1.1

208.00

269.87

mg/l

2.47

216

COPD, hospital admissions

753

1.00

0.00

1.1

373.76

315.94

mg/l

0.28

660

Mental retardation

125

1.04

0.00

1.2

1.1

218.82

241.57

mg/l

0.28

109

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

345

0.99

0.00

1.1

348.09

332.82

mg/l

0.18

314

Benign neoplasm of breast

321

1.00

0.00

1.2

1.1

250.93

225.93

mg/l

0.28

281

Obstructed labour due to maternal pelvic abnormality

429

1.00

0.00

1.1

220.95

235.27

mg/l

0.40

376

Postpartum haemorrhage due to retained placenta

501

1.00

0.00

1.1

197.68

202.69

mg/l

0.14

445

Pedal cyclist injured in transport accident

779

1.00

0.00

1.1

234.49

259.10

mg/l

0.81

684

Struck by thrown, projected or falling objec

143

0.98

0.00

1.1

214.33

279.38

mg/l

—

124

Mental retardation, wide definition

132

0.98

0.00

1.2

1.1

218.82

239.35

mg/l

0.26

115

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

0.0

1.1

—

260.88

—

Other specified disorders of external ear

1.01

0.00

1.1

1.0

196.43

298.48

mg/l

—

Benign neoplasm: Scrotum

0.00

0.0

1.2

—

328.00

—

Benign neoplasm: Skin of scalp and neck

0.93

0.00

1.0

437.00

223.29

mg/l

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.0

1.1

—

262.29

—

Organ-limited amyloidosis

0.00

0.0

1.2

—

215.33

—

Otorrhoea

0.00

0.0

1.0

—

163.00

—

0.92

0.00

1.1

191.25

202.07

mg/l

—

Drug-induced thyroiditis

0.00

0.0

1.1

—

248.29

—

Benign neoplasm: Skin of scalp and neck

0.93

0.00

1.0

437.00

228.54

mg/l

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.0

—

266.40

—

Nutritional marasmus

0.00

0.0

1.0

—

251.33

—

Other disorders following mastoidectomy

0.00

0.0

1.2

—

275.00

—

Plasmodium falciparum malaria

0.00

0.0

1.2

—

263.33

—

Shigellosis

0.00

0.0

1.2

—

338.20

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.0

1.1

—

231.56

—

Noninfective disorders of pinna

0.00

0.0

1.0

—

239.29

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.1

—

262.57

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.0

1.2

—

188.20

—

Benign neoplasm: Skin of trunk

0.96

0.00

1.0

1.1

173.51

253.81

mg/l

—

Benign neoplasm: Vertebral column

0.00

0.0

1.1

—

278.11

—

Profound mental retardation

0.00

0.0

1.0

—

214.80

—

Sickle-cell disorders

0.00

0.0

1.0

—

253.63

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.0

—

226.83

—

0.92

0.00

1.1

185.00

195.17

mg/l

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.0

—

222.20

—

Paget disease

0.00

0.0

1.0

—

246.11

—

Hirsprung

0.00

0.0

1.0

—

452.60

—

Other congenital malformations of eye

0.00

0.0

1.0

—

139.83

—

Filling of root of tooth

0.95

0.00

1.0

1.1

210.14

264.38

mg/l

—

Chondrosarcoma

0.00

0.0

1.0

—

240.67

—

Congenital glaucoma

0.00

0.0

1.0

—

154.20

—

Other congenital malformations of kidney

0.00

0.0

1.1

—

230.89

—

Chronic thyroiditis

0.00

0.0

1.0

—

233.14

—

Crohn's disease (strict) with PSC

0.00

0.0

1.0

—

256.60

—

Eccrine sweat disorders

0.00

0.0

1.0

—

315.17

—

Benign neoplasm: Rectosigmoid junction

0.92

0.00

1.1

241.43

249.10

mg/l

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.1

—

258.88

—

Pterygium

0.98

0.00

1.2

1.1

326.00

271.70

mg/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.00

0.00

1.0

1.1

237.60

213.70

mg/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.0

1.0

—

174.67

—

Alcoholic cardiomyopathy

0.00

0.0

1.1

—

299.43

—

ILD medications: nintedanib

0.00

0.0

1.0

—

249.33

—

Sequelae of hyperalimentation

0.00

0.0

1.0

—

252.00

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.1

—

278.14

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.0

—

262.60

—

Congenital malformation of biliary tract

0.00

0.0

1.1

—

352.11

—

Benign neoplasm: Ciliary body

0.00

0.0

1.2

—

250.50

—

Injury of blood vessels of thorax

0.00

0.0

1.2

—

310.20

—

Digestive system disorders of fetus and newborn

0.00

0.0

1.0

—

123.60

—

Carcinoma in situ of oral cavity

0.00

0.0

1.1

—

297.29

—

Other disturbances of cerebral status of newborn

0.00

0.0

1.0

—

95.50

—

Diphtheria

0.00

0.0

1.0

—

260.00

—

Need for immunization against single bacterial diseases

0.00

0.0

1.0

—

113.43

—

Other fibroblastic disorders

0.00

0.0

1.0

—

214.40

—

Ascorbic acid deficiency

0.00

0.0

1.0

—

154.80

—

Benign neoplasm: Skin of trunk

1.01

0.00

1.0

1.1

173.51

237.44

mg/l

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.1

—

246.57

—

Nezelof syndrome

0.00

0.0

1.0

—

214.00

—

Benign neoplasm: Scrotum

0.00

0.0

1.1

—

330.56

—

Other acute skin changes due to ultraviolet radiation

0.90

0.00

1.3

1.1

188.86

243.77

mg/l

—

Erectile dysfunction, exclusion

0.00

0.0

1.1

—

245.71

—

Deaf mutism, not elsewhere classified

0.00

0.0

1.1

—

321.75

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.0

—

182.00

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.1

—

108.78

—

Induced delusional disorder

0.00

0.0

1.2

—

278.80

—

Ototoxic hearing loss

0.00

0.0

1.0

—

207.80

—

Cystic kidney disease

0.95

0.00

1.0

1.1

409.00

252.31

mg/l

—

Crushing injury of hip and thigh

0.00

0.0

1.0

—

235.80

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.0

1.0

—

245.75

—

Folliculitis decalvans

0.00

0.0

1.2

—

331.17

—

Benign neoplasm of thyroid gland

1.00

0.00

1.1

269.29

223.26

mg/l

—

Benign neoplasm: Vertebral column

0.00

0.0

1.1

—

249.89

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.1

—

165.33

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

305.13

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

258.60

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

0.0

1.1

—

247.78

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.0

—

226.83

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

270.33

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

0.0

1.0

—

98.52

—

Alpha thalassaemia

0.00

0.0

1.0

—

211.20

—

Typhoid and paratyphoid fevers

0.00

0.0

1.1

—

240.57

—

Benign neoplasm: Ciliary body

0.00

0.0

1.2

—

235.50

—

Mechanical strabismus

0.00

0.0

1.2

—

227.83

—

Erythema multiforme

0.89

0.00

1.2

1.1

253.20

227.17

mg/l

—

Cystic fibrosis

0.00

0.0

1.0

—

237.17

—

Other renal tubulo-interstitial diseases

1.00

0.00

1.0

1.1

292.83

225.17

mg/l

—

Mixed hyperlipidaemia

0.98

0.00

1.3

1.0

248.00

301.40

mg/l

—

Other rupture of muscle

0.00

0.0

1.0

—

278.60

—

Thyroid crisis or storm

0.00

0.0

1.1

—

274.25

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

1.2

—

280.83

—

Defect, injury or illness of face

0.00

0.0

1.2

—

338.40

—

Serous carcinoma of ovary

0.88

0.00

1.0

1.1

415.80

238.20

mg/l

—

Traumatic amputation of ankle and foot

0.00

0.0

1.2

—

263.33

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.0

1.0

—

202.00

—

Immunodeficiency associated with other major defects

0.00

0.0

1.0

—

231.29

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

282.40

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.1

—

279.43

—

Carcinoma in situ of oral cavity

0.00

0.0

1.2

—

289.83

—

Benign neoplasm of thyroid gland

0.96

0.00

1.1

269.29

245.86

mg/l

—

Benign neoplasm: Rectosigmoid junction

1.01

0.00

1.1

241.43

248.73

mg/l

—

Hypergammalglobulinemia, unspecified

0.00

0.0

1.0

—

228.00

—

Carcinoma in situ of oropharynx, excluding all cancers

0.00

0.0

1.2

—

295.17

—

Qualitative platelet defects

0.00

0.0

1.1

—

248.29

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

287.88

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS